No subject
Sat Feb 18 11:22:33 BRST 2006
phlebotomine were done to the insect monitoring. The collection was done
in an area of infection of American cutaneous leishmaniasis in the
basin of the Araguari River in the municipality of Uberlandia (MG).The
first collection was made in May (a cold, damp month), the second in
June 2000 (a cold, dry month) the third in October 2000 (a hot, dry
month) and the fourth in January 2001 (a hot, rainy month).CDC and
Shannon light traps were used 6551 phlebotomne were captured and
identified, 1990 male and 4562 female, comprised of two lines (Lutzomyia
and Brumptomyia) and 8 species. Lutzomyia intermedia predominated with
the largest number of specimens (6531), which accounted for 99,7% of the
collected insects. In the four collections, it was observed that
Lutzomyia intermedia manifested a preference for the month preceding the
rainy season, with its high temperatures and humidity.
PMID: 15712555
TITLE: Diagnosis of cutaneous leishmaniasis by fine needle aspiration cytology:
a report of 66 cases.
AUTHORS: Masoom Kassi, Pashtoon Murtaza Kasi
REFERENCE: Trop Doct 2005 Jan 35(1):50-1
PMID: 15721387
TITLE: Tuftsin-bearing liposomes as antibiotic carriers in treatment of
macrophage infections.
AUTHORS: C M Gupta, W Haq
REFERENCE: Methods Enzymol 2005 391():291-304
Tuftsin is a tetrapeptide (Thr-Lys-Pro-Arg) that specifically binds
monocytes, macrophages, and polymorphonuclear leukocytes and potentiates
their natural killer activity against tumors and pathogens. The
antimicrobial activity of this peptide is significantly increased by
attaching at the C-terminus a fatty acyl residue through the
ethylenediamine spacer arm. This activity is further augmented by
incorporating the modified tuftsin in the liposomes. The tuftsin-bearing
liposomes not only enhance the host's resistance against a variety of
infections but also serve as useful vehicles for the site-specific
delivery of drugs in a variety of macrophage-based infections, such as
tuberculosis and leishmaniasis.
PMID: 15613100
TITLE: Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a
lineage-specific marker in the reactive hemophagocytic syndrome.
AUTHORS: Dominik J Schaer, Boris Schleiffenbaum, Michael Kurrer, Alexander
Imhof, Esther Bächli, Jörg Fehr, Holger J Moller, Soren K Moestrup, Andreas
Schaffner
AFFILIATION: Department of Medicine, University Hospital, Zurich, Switzerland.
schaer_dominik at hotmail.com
REFERENCE: Eur J Haematol 2005 Jan 74(1):6-10
Reactive hemophagocytic syndrome (RHS) is a disease of overwhelming
macrophage activity triggered by infection, malignancy or autoimmune
disorders. Currently used laboratory markers for the quantitative
assessment of monocyte/macrophage activation lack lineage-restricted
expression patterns and thus specificity. Serum levels of the macrophage
specific scavenger receptor CD163 were determined by enzyme-linked
immunosorbent assay (ELISA) and were found to be highly increased in
patients with RHS (median 39.0 mg/L). Significantly lower levels were
determined in patients with sepsis (median 9.1 mg/L), acute
mononucleosis (median 8.2 mg/L), Leishmania infection (median 6.7 mg/L)
and healthy controls (median 1.8 mg/L). Follow-up of patients with a
relapsing course of the disease revealed close correlations of sCD163
with clinical disease activity, serum ferritin and other markers of
macrophage activity. Large sinusoidal accumulations of CD163 expressing
macrophages actively engaged in phagocytosis of blood cells were
detected in spleen sections of RHS patients. Our data suggests sCD163 to
be a macrophage-specific marker in patients with disorders of
inappropriate macrophage activation.
PMID: 15715249
TITLE: Diagnostic value of rK39 dipstick in zoonotic visceral leishmaniasis in
Turkey.
AUTHORS: Seray Ozensoy Toz, Kwang-Poo Chang, Yusuf Ozbel, M Ziya Alkan
AFFILIATION: Department of Parasitology, Ege University Medical School, 35100
Bornova-Izmir, Turkey.
REFERENCE: J Parasitol 2004 Dec 90(6):1484-6
K39 is a repetitive immunodominant epitope in a kinesin-related protein
expressed predominantly in the amastigotes of visceral Leishmania spp.
Enzyme immunoassays of patient's sera with recombinant K39 (rK39) proved
to be highly specific and sensitive for diagnosis of active visceral
leishmaniasis (VL, kala-azar). The same assays in dipstick format were
also found effective for diagnosis of both human VL (HVL) and canine VL
(CanVL) in most endemic areas of these diseases. Fifty-eight human
patients and 22 dogs, clinically suspected of kala-azar, were screened
with rK39 dipstick in comparison with the conventional methods of
diagnosis, i.e., microscopic examinations of bone marrow and lymph node
aspirates and immunofluorescent antibody tests (IFAT), respectively.
Sixteen patients and 12 dogs were found to be rK39 dipstick positive.
The results were corroborated with those of parasitological examinations
, except 1, rK39-positive but smear-negative, case in each group. IFAT
of the 2 discordant cases gave positive results. The rK39 dipstick is
thus reliable for diagnosis of both HVL and canVL cases in Turkey.
PMID: 15720898
TITLE: Is hypertriglyceridaemia a new concept for visceral leishmaniasis?
AUTHORS: Omer Erdeve, Yildaz Dallar, Zeynep Siklar
AFFILIATION: Department of Pediatrics, Ankara Education and Research Hospital,
Ankara, Turkey.
REFERENCE: Ann Trop Paediatr 2004 Dec 24(4):369
PMID: 15356347
TITLE: Leashing Leishmania.Some old mice fight parasitic infection better than
young mice do.
AUTHORS: R John Davenport
REFERENCE: Sci Aging Knowledge Environ 2004 Sep 2004(36):nf82
PMID: 15533297
TITLE: Efficacy of Trypan: a diminazene based drug as antileishmanial agent.
AUTHORS: J C Macharia, A J Bourdichon, M M Gicheru
AFFILIATION: Department of Parasitology, Institute of Primate Research, National
Museums of Kenya, P.O. Box 24481, Karen, Nairobi, Kenya.
REFERENCE: Acta Trop 2004 Nov-Dec 92(3):267-72
Trypan, a diamidine based drug, was tested as an antileishmanial agent.
Duplicate cultures of both Leishmania major and Leishmania donovani
promastigotes in M199 medium and Trypan at various concentrations were
tested. The cultures were incubated at 25 degrees C and parasites
counted at 48 h interval, and the data generated was used to establish
growth inhibition curves. Drug-free cultures were included to serve as
control. In the in vivo study, a total of 40 BALB/c mice were divided
into five groups of 8 mice each. They were infected with 2 x 10(6)
promastogotes on the left footpad. Two groups were treated with 70
microg/ml of Trypan, a total of 500 microl used immediately after
infection, one group by topical application and the other administered
intraperitoneally. The treatments were repeated for the two other groups
10 weeks post infection, one by topical application and the other
administered intraperitoneally. One group was not treated and thus
served as control. Footpad sizes were measured using Vernier calliper
every 2 weeks for 21 weeks. In the in vitro studies, Trypan inhibited
growth of either L. major or L. donovani promastigotes in all the
concentrations tested with more dramatic inhibition in high
concentrations. Based on the in vivo studies, it was evident that Trypan
had effect on L. major infected lesions when applied topically
immediately after infection. However, there was no effect when treatment
commenced after the lesions were established. The data is discussed.
********************************************************************************************************************
The following references are revised files and are brought to you in accordance
to license agreement with the NLM.
********************************************************************************************************************
PMID: 15579454
TITLE: Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the
control of Leishmania donovani infection.
AUTHORS: Christian R Engwerda, Manabu Ato, Simona Stäger, Clare E Alexander,
Amanda C Stanley, Paul M Kaye
AFFILIATION: Immunology and Infection Laboratory and Australian Centre for
International and Tropical Health and Nutrition, Queensland Institute of
Medical Research, Herston, Queensland, Australia 4029. chrise at qimr.edu.au
REFERENCE: Am J Pathol 2004 Dec 165(6):2123-33
Tumor necrosis factor (TNF) is critical for the control of visceral
leishmaniasis caused by Leishmania donovani. However, the role of the
related cytokine lymphotoxin (LT) alpha in this infection is unknown.
Here we report that C57BL/6 mice deficient in TNF (B6.TNF(-/-)) or LT
alpha (B6.LT alpha(-/-)) have increased susceptibility to hepatic L.
donovani infection. Furthermore, the outcome of infection in bone marrow
chimeric mice is dependent on donor hematopoietic cells, indicating
that developmental defects in lymphoid organs were not responsible for
increased susceptibility to L. donovani. Although both LT alpha and TNF
regulated the migration of leukocytes into the sinusoidal area of the
infected liver, their roles were distinct. LT alpha was essential for
migration of leukocytes from periportal areas, an event consistent with
LT alpha-dependent up-regulation of VCAM-1 on liver sinusoid lining
cells, whereas TNF was essential for leukocyte recruitment to the liver
. During visceral leishmaniasis, both cytokines were produced by radio-
resistant cells and by CD4(+) T cells. LT alpha and TNF production by
the former was required for granuloma assembly, while production of
these cytokines by CD4(+) T cells was necessary to control parasite
growth. The production of inducible nitric oxide synthase was also found
to be deficient in TNF- and LT alpha-deficient infected mice. These
results demonstrate that both LT alpha and TNF are required for control
of L. donovani infection in noncompensatory ways.
PMID: 15305696
TITLE: [Nitric oxide and anti-protozoan chemotherapy]
AUTHORS: L Gradoni, P Ascenzi
AFFILIATION: Reparto di Malattie Trasmesse da Vettori e Sanità Internazionale,
Dipartimento MIPI, Istituto Superiore di Sanità , Roma, Italy.
REFERENCE: Parassitologia 2004 Jun 46(1-2):101-3
Constitutive nitric oxide (NO) is generated by constitutively expressed
types of NO-synthase enzymes (NOS-I and -III), being involved in
physiological processes such as nervous transmission and vasodilatation
. Inducible NO, synthesized by the NO-synthase isoform NOS-II, is an
anti-pathogen and tumoricidal agent. However, inducible NO production
requires a tight control because of cytotoxic and immune-modulation
activity. NO produced by human and canine macrophages has long been
demonstrated to be involved in the intracellular killing of Leishmania.
Mechanisms of parasite survival and persistence in the host have been
throughly investigated, and include suppression of NOS-II and the
parasite entry into NOS-II negative cells. Both intracellular and
extracellular morphotypes of Trypanosoma cruzi are killed by NO in vitro
and in vivo, although a role of NO in the pathogenesis of heart disease
has been reported. Killing of extracellular protozoa such as
Trichomonas vaginalis and Naegleria fowleri by activated macrophages is
also mediated by NO. The main control of Plasmodium spp infection in
human and murine hepatocytes, and in human monocytes is achieved by NO-
mediated mechanisms. Protection from severe malaria in African children
has been found associated with polymorphisms of the NOS-II promoter;
however, a pathogenic role of endogenous NO has been documented in
cerebral malaria. Although several macromolecules are putative NO
targets, recent experimental work has shown that NO-releasing compounds
inhibit cysteine proteases (CP) of P. falciparum, T. cruzi and L.
infantum in a dose-dependent manner. CPs are present in a wide range of
parasitic protozoa and appear to be relevant in several aspects of the
life cycle and of the parasite-host relationships. Comparative analysis
of 3-D amino acid sequence models of CPs from a broad range of living
organisms, from viruses to mammals, suggests that the Sy atom of the Cys
catalytic residue undergoes NO-dependent chemical modification (S-
nytrosilation and disulfide bridge formation), with the concomitant loss
of enzyme activity. The NO-donor S-nitroso-N-acetilpenicillamine (SNAP
) was shown to kill T. cruzi epimastigotes and L. infantum promastigotes
in culture, while a combination of nitrite plus acid organic salts was
highly effective against L. major amastigotes in mouse macrophages. A
parasitostatic effect--with both encystation and excystation inhibition
--of S-nitrosoglutathione and spermine-NONOate was documented in
trophozoite cultures of Giardia duodenalis. Recently, a novel
formulation of metronidazole bearing a NO-releasing group was found to
enhance significantly the in vitro killing of Entamoeba histolytica
trophozoites, compared to metronidazole. So far, only two clinical
studies were performed on human patients, suffering from cutaneous
leishmaniasis. In one study, 16 Ecuadorean patients were treated with a
SNAP cream administered on lesions for 10 days. All lesions were
parasitologically cured and clinically healed by day 30. In the second
study, a different NO-producing cream (basically nitrite in acidic
environment) was employed to treat 40 Syrian patients. Only 28% of them
showed improvement and 12% were cured by day 60. In conclusion, despite
the wide evidence that NO can be regarded as a natural anti-protozoal
weapon, little efforts have been made to develop and test NO-based drugs
in human medicine. This is mainly due to the difficulty in designing
suitable chemical carriers able to release the right amount of NO, in
the right place and in the right time, to avoid toxic effects against
non-target host cells.
PMID: 15187137
TITLE: Protection against progressive leishmaniasis by IFN-beta.
AUTHORS: Jochen Mattner, Alexandra Wandersee-Steinhäuser, Andreas Pahl, Martin
Röllinghoff, Gerard R Majeau, Paula S Hochman, Christian Bogdan
AFFILIATION: Institute of Clinical Microbiology, Immunology and Hygiene,
University of Erlangen-Nuremberg, Erlangen, Germany.
REFERENCE: J Immunol 2004 Jun 172(12):7574-82
Type I IFNs (IFN-alphabeta) exert potent antiviral and immunoregulatory
activities during viral infections, but their role in bacterial or
protozoan infections is poorly understood. In this study, we demonstrate
that the application of low, but not of high doses of IFN-beta protects
60 or 100% of BALB/c mice from progressive cutaneous and fatal visceral
disease after infection with a high (10(6)) or low (10(4)) number of
Leishmania major parasites, respectively. IFN-beta treatment of BALB/c
mice restored the NK cell cytotoxic activity, increased the lymphocyte
proliferation, and augmented the production of IFN-gamma and IL-12 in
the draining lymph node. Low, but not high doses of IFN-beta caused
enhanced tyrosine phosphorylation of STAT1 and STAT4, suppressed the
levels of suppressor of cytokine signaling-1, and up-regulated the
expression of inducible NO synthase in vivo. The IFN-beta-induced
increase of IFN-gamma production was dependent on STAT4. Protection by
IFN-beta strictly required the presence of inducible NO synthase. In the
absence of STAT4 or IL-12, IFN-beta led to an amelioration of the
cutaneous and visceral disease, but was unable to prevent its
progression. These results identify IFN-beta as a novel cytokine with a
strong, dose-dependent protective effect against progressive cutaneous
leishmaniasis that results from IL-12- and STAT4-dependent as well as -
independent events.
PMID: 15109961
TITLE: Cathepsin L is crucial for a Th1-type immune response during Leishmania
major infection.
AUTHORS: Kotaro Onishi, Yang Li, Kazunari Ishii, Hajime Hisaeda, Lijun Tang,
Xuefeng Duan, Teruki Dainichi, Yoichi Maekawa, Nobuhiko Katunuma, Kunisuke
Himeno
AFFILIATION: Department Microbiology and Immunology, Faculty of Medical
Sciences, Kyushu University, Fukuoka 812-8582, Japan. koonishi at jikei.ac.jp
REFERENCE: Microbes Infect 2004 Apr 6(5):468-74
Prior to the activation of CD4+ T cells, exogenous proteins are digested
by endo/lysosomal enzymes in antigen-presenting cells (APCs) to produce
antigenic peptides that are presented on MHC class II molecules. In the
studies described here, the functional significance of cathepsin L for
antigen processing and Th1/Th2 differentiation in experimental
leishmaniasis was investigated. We first demonstrated that cathepsin L
is one of the candidates for endo/lysosomal enzymes in the processing of
soluble Leishmania antigen (SLA) by using CLIK148, a specific inhibitor
of cathepsin L. Treatment of BALB/c or DBA/2 mice with CLIK148
exacerbated the disease by enhancing an SLA-specific Th2-type response
such as IL-4 production. CLIK148 did not exert any direct influence on
Leishmania major promastigotes themselves or on the course of L. major
infection in SCID mice. Taken together, these findings suggest that
treatment of host mice with CLIK148 affects the processing of SLA in
APCs, resulting in the potentiation of Th2-type immune responses and
thus leading to exacerbation of the disease. Furthermore, endo/lysosomal
cathepsin L was found to be functionally distinct from previously
described cathepsins B and D.
PMID: 15039311
TITLE: Toll-like receptor 4 contributes to efficient control of infection with
the protozoan parasite Leishmania major.
AUTHORS: Pascale Kropf, Marina A Freudenberg, Manuel Modolell, Helen P Price,
Shanti Herath, Simone Antoniazi, Chris Galanos, Deborah F Smith, Ingrid
Müller
AFFILIATION: Faculty of Medicine, Department of Immunology, Imperial College
London, London, United Kingdom.
REFERENCE: Infect Immun 2004 Apr 72(4):1920-8
The essential role of Toll-like receptors (TLR) in innate immune
responses to bacterial pathogens is increasingly recognized, but very
little is known about the role of TLRs in host defense against
infections with eukaryotic pathogens. For the present study, we
investigated whether TLRs contribute to the innate and acquired immune
response to infection with the intracellular protozoan parasite
Leishmania major. Our results show that TLR4 contributes to the control
of parasite growth in both phases of the immune response. We also
addressed the mechanism that results in killing or growth of the
intracellular parasites. Control of parasite replication correlates with
the early induction of inducible nitric oxide synthase in TLR4-
competent mice, whereas increased parasite survival in host cells from
TLR4-deficient mice correlates with a higher activity of arginase, an
enzyme known to promote parasite growth. This is the first study showing
that TLR4 contributes to the effective control of Leishmania infection
in vivo.
PMID: 14768057
TITLE: Control of Leishmania major in the absence of Tyk2 kinase.
AUTHORS: Ulrike Schleicher, Jochen Mattner, Martin Blos, Heike Schindler, Martin
Röllinghoff, Marina Karaghiosoff, Mathias Müller, Gabriele Werner-Felmayer,
Christian Bogdan
AFFILIATION: Institute of Clinical Microbiology, Immunology and Hygiene,
University of Erlangen-Nuremberg, Erlangen, Germany.
REFERENCE: Eur J Immunol 2004 Feb 34(2):519-29
IL-12 is indispensable for the control of many intracellular pathogens,
but the components of the signaling pathway that are essential for its
function in vivo are incompletely understood. Here, we investigated in
the Leishmania major mouse model whether Tyk2 kinase is required for the
generation of a protective immune response. Unlike C57BL/6 controls,
Tyk2(-/-)mice developed severe skin lesions after infection that
frequently ulcerated, but ultimately healed. NK cell cytotoxicity was
absent in infected Tyk2(-/-) mice, even after IL-12 pretreatment, which
correlated with a STAT4 activation defect. IFN-alpha / beta, which was
still able to activate STAT1 in Tyk2(-/-) NK cells, reconstituted their
cytotoxic activity, but not their IL-12 responsiveness. The IL-12-
induced production of IFN-gamma by NK cells and CD8(+) T cells was
strongly suppressed in Tyk2(-/-) mice at day 1 of infection, but partly
regained during the late phase of infection. Tyk2(-/-) CD4(+) T cells
developed into Th1 cells (although in a delayed fashion) and infected
Tyk2(-/-) mice expressed normals levels of inducible NO synthase. Thus,
Tyk2 is required for the IL-12 response of NK cells and CD8(+) T cells
in L. major-infected mice, but not for the generation of Th1 cells and
the ultimate control of the disease.
PMID: 12933876
TITLE: Both the Fas ligand and inducible nitric oxide synthase are needed for
control of parasite replication within lesions in mice infected with Leishmania
major whereas the contribution of tumor necrosis factor is minimal.
AUTHORS: Reza Chakour, Reto Guler, Mélanie Bugnon, Cindy Allenbach, Irène
Garcia, Jacques Mauël, Jacques Louis, Fabienne Tacchini-Cottier
AFFILIATION: The World Health Organization Immunology Research and Training
Center and Institute of Biochemistry, University of Lausanne, Epalinges,
Switzerland.
REFERENCE: Infect Immun 2003 Sep 71(9):5287-95
Following infection with the protozoan parasite Leishmania major, C57BL/
6 mice develop a small lesion that heals spontaneously. Resistance to
infection is associated with the development of CD4(+) Th1 cells
producing gamma interferon (IFN-gamma) and tumor necrosis factor (TNF),
which synergize in activating macrophages to their microbicidal state.
We show here that C57BL/6 mice lacking both TNF and Fas ligand (FasL) (
gld TNF(-/-) mice) infected with L. major neither resolved their lesions
nor controlled Leishmania replication despite the development of a
strong Th1 response. Comparable inducible nitric oxide synthase (iNOS)
activities were detected in lesions of TNF(-/-), gld TNF(-/-), and gld
mice, but only gld and gld TNF(-/-) mice failed to control parasite
replication. Parasite numbers were high in gld mice and even more
elevated in gld TNF(-/-) mice, suggesting that, in addition to iNOS, the
Fas/FasL pathway is required for successful control of parasite
replication and that TNF contributes only a small part to this process.
Furthermore, FasL was shown to synergize with IFN-gamma for the
induction of leishmanicidal activity within macrophages infected with L
. major in vitro. Interestingly, TNF(-/-) mice maintained large lesion
size throughout infection, despite being able to largely control
parasite numbers. Thus, IFN-gamma, FasL, and iNOS appear to be essential
for the complete control of parasite replication, while the
contribution of TNF is more important in controlling inflammation at the
site of parasite inoculation.
PMID: 12884305
TITLE: TNF-alpha mediates the induction of nitric oxide synthase in macrophages
but not in neutrophils in experimental cutaneous leishmaniasis.
AUTHORS: Simone G Fonseca, Pedro R T Romão, Florêncio Figueiredo, Ruth H
Morais, Hermênio C Lima, Sérgio H Ferreira, Fernando Q Cunha
AFFILIATION: Department of Biochemistry and Immunology, School of Medicine of
Ribeirão Preto, University of São Paulo, São Paulo, Brazil.
REFERENCE: Eur J Immunol 2003 Aug 33(8):2297-306
Leishmania major infection in C57BL/6 mice is controlled by the
activation of a Th1 response and nitric oxide (NO) production by
macrophages. TNF-alpha is considered one of the most important cytokines
involved in this response. In the present study, we investigated the
expression of nitric oxide synthase (iNOS) in the inflammatory cells
present in the lesion and draining lymph nodes, and the cytokine
production by lymph node cells in animals treated with anti-TNF-alpha.
Our results demonstrated that mice treated with anti-TNF-alpha presented
an increase in the number of parasites and the size of lesion, but they
were able to control the infection. The increase in the lesion size
correlated to the reduction of iNOS activity in the draining lymph nodes
. Furthermore, the anti-TNF-alpha treatment also reduced the expression
of iNOS in the macrophages, but did not affect the iNOS expression in
the neutrophils. The anti-TNF-alpha mAb did not reduce the iNOS
expression in IFN-gamma-stimulated L. major infected neutrophils in
vitro. Anti-TNF-alpha mAb treatment caused an increase in the production
of IFN-gamma and IL-10 by the lymph node cells from infected mice.
Consequently, these results suggest that neutrophils do not respond to
anti-TNF-alpha treatment and might be a source of NO to control L. major
infection under these experimental conditions.
PMID: 12874364
TITLE: Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to
the development of hepatic granulomas with optimal antileishmanial activity.
AUTHORS: Simona Stäger, James Alexander, K Christine Carter, Frank Brombacher,
Paul M Kaye
AFFILIATION: Department of Infectious and Tropical Diseases, London School of
Hygiene and Tropical Medicine, London, United Kingdom.
REFERENCE: Infect Immun 2003 Aug 71(8):4804-7
The roles of interleukin-4 (IL-4) and IL-13 in the regulation of
immunity to Leishmania donovani infection are still poorly understood.
Here we show that the increased parasite load observed in IL-4(-/-) and
IL-4 receptor alpha(-/-) mice correlates with retarded granuloma
maturation and antileishmanial activity and that the increased parasite
load observed in IL-4 receptor alpha(-/-) mice correlates with increased
NOS2 expression and decreased serum gamma interferon levels. IL-4 and
IL-13 appear to play little role in regulating collagen deposition in L
. donovani-induced granulomas.
PMID: 12870129
TITLE: Determinants of response to interleukin-10 receptor blockade
immunotherapy in experimental visceral leishmaniasis.
AUTHORS: Henry W Murray, Andre L Moreira, Cristina M Lu, Jennifer L DeVecchio,
Maki Matsuhashi, Xiaojing Ma, Frederick P Heinzel
AFFILIATION: Department of Medicine, Weill Medical College of Cornell
University, New York, USA. hwmurray at med.cornell.edu.
REFERENCE: J Infect Dis 2003 Aug 188(3):458-64
In established Leishmania donovani visceral infection in normal mice,
anti-interleukin (IL)-10 receptor (IL-10R) monoclonal antibody (MAb)
treatment induced intracellular parasite killing within liver
macrophages. IL-10R blockade maintained IL-12 protein 40, markedly
increased interferon (IFN)-gamma serum levels, and enhanced tissue
inducible nitric oxide synthase (iNOS) expression and granuloma assembly
. Optimal MAb-induced killing, including synergism with antimony
chemotherapy, required endogenous IL-12 and/or IFN-gamma and at least
one IFN-gamma-regulated macrophage mechanism-iNOS or phagocyte oxidase.
However, in IFN-gamma knockout mice, anti-IL-10R also induced both
granuloma formation and leishmanistatic activity. As judged by IL-10R
blockade, endogenous IL-10 primarily regulates killing in L. donovani
infection by suppressing production of and responses to the Th1 cell-
type cytokines, IL-12, and IFN-gamma. However, because anti-IL-10R also
released IFN-gamma-independent effects, IL-10 appears to act more
broadly and suppresses multiple antileishmanial mechanisms.
PMID: 12778468
TITLE: Targeting of immunostimulatory DNA cures experimental visceral
leishmaniasis through nitric oxide up-regulation and T cell activation.
AUTHORS: Neeta Datta, Snigdha Mukherjee, Lopamudra Das, Pijush K Das
AFFILIATION: Molecular Cell Biology Laboratory, Indian Institute of Chemical
Biology, Calcutta, India.
REFERENCE: Eur J Immunol 2003 Jun 33(6):1508-18
Active targeting of CpG-containing oligodeoxynucleotide (CpG-ODN) to
macrophages was studied by incorporating it in mannose-coated liposomes
, using visceral leishmaniasis as the model macrophage disease.
Mannosylated liposomal CpG-ODN was more effective than liposomal or free
CpG-ODN in inhibiting amastigote multiplication within macrophages.
Moreover, in a 60-day mouse model of visceral leishmaniasis, complete
elimination of spleen parasite burden was achieved by mannosylated
liposomal CpG-ODN, compared to 62% and 81% parasite suppression by free
and liposomal ODN, respectively, at a similar dose. Although in vitro
exposure of CpG-ODN did not induce marked nitric oxide (NO) generation
by macrophages, considerably enhanced amount of NO was generated by
macrophages of CpG-ODN-treated animals. Their splenocytes secreted
soluble factors required for the induction of NO generation, and the
increased NO generation was paralleled by an increase in antileishmanial
activity. Inducible NO generation was suppressed by treating splenocyte
supernatants with anti-IFN-gamma or anti-IL-12 antibodies, whereas in
vivo administration of these anti-cytokine Ab along with CpG-ODN
reversed protection against infection. CpG-ODN treatment resulted in
reduced levels of IL-4, but increased levels of IFN-gamma, IL-12 and
inducible NO synthase in infected spleen cells, which was magnified by
encapsulation in mannose-coated liposomes. This targeted treatment was
not only curative, but it also imparted resistance to reinfection. These
results represent a general approach for intracellular targeting of CpG
-ODN, which effectively enhances its therapeutic potential in
redirecting curative Th1 responses in Th2-driven disorders.
PMID: 12780717
TITLE: Nitric oxide and cellular immunity in experimental cutaneous
leishmaniasis.
AUTHORS: N L DÃaz, M Fernández, E Figueira, R RamÃrez, I B Monsalve, F J
Tapia
AFFILIATION: Laboratorio de BiologÃa Molecular, Instituto de Biomedicina,
Universidad Central de Venezuela, Caracas, Venezuela.
REFERENCE: Clin Exp Dermatol 2003 May 28(3):288-93
We examined the local and systemic production of nitric oxide (NO) and
the pattern of cytokine during the course of Leishmania mexicana
infection in susceptible BALB/c and resistant C57BL/6 mice. NO
derivatives were measured in serum, and the expression of inducible
nitric oxide synthase (iNOS), interferon (IFN-gamma), interleukin (IL-4
) and epidermal Langerhans cells (LC) was measured in the lesions by
immunohistology. Circulating NO concentrations, iNOS+ cell density, IFN-
gamma+ Th1 cells and CD205+ Langerhans cells were higher in early
lesions of resistant C57BL/6 mice. In contrast, susceptible BALB/c mice
developed chronic and progressive lesions with a predominance of IL-4+
Th2 cells. In both susceptible and resistant mice, lesion size and lymph
node volume followed a similar course. The early local and systemic
production of NO in resistant mice may be related with the premature
production of IFN-gamma observed, contributing to the resolution of the
lesion.
PMID: 12731047
TITLE: Organ-specific and stage-dependent control of Leishmania major infection
by inducible nitric oxide synthase and phagocyte NADPH oxidase.
AUTHORS: Martin Blos, Ulrike Schleicher, F Janaina Soares Rocha, Udo Meissner,
Martin Röllinghoff, Christian Bogdan
AFFILIATION: Institute of Clinical Microbiology, Immunology and Hygiene,
University of Erlangen-Nuremberg, Erlangen, Germany.
REFERENCE: Eur J Immunol 2003 May 33(5):1224-34
In the Leishmania major mouse model of cutaneous leishmaniasis inducible
nitric oxide synthase (iNOS) is crucial for the killing of the parasite
in the skin and draining lymph node. However, the effector mechanism
operating against L. major in the spleen is unknown. As reactive oxygen
intermediates might play a role, we analyzed macrophages and mice
lacking the gp91phox subunit of the phagocyte NADPH oxidase (phox) for
their ability to combat an infection with L. major. Macrophages from
wild-type and gp91phox(-/-) mice had an equal capacity to kill L. major
after activation by cytokines. Unlike iNOS, the activity of phox was
dispensable for the resolution of the acute skin lesions and exerted
only a limited effect on the containment of the parasites in the
draining lymph node, but was essential for the clearance of L. major in
the spleen. During the chronic phase of infection, parasites persisted
at high levels in gp91phox(-/-) mice, and cutaneous lesions re-emerged
in approximately 60% of these mice. gp91phox deficiency did not impair
the expression of iNOS or the production of TNF and IFN-gamma. These
results demonstrate that iNOS and phox are both required for the control
of L. major in vivo and display unexpected organ- and stage-specific
anti-leishmanial effects.
PMID: 12644314
TITLE: Infection pattern and immune response in the spleen and liver of BALB/c
mice intracardially infected with Leishmania donovani amastigotes.
AUTHORS: Piyali Mukherjee, Asish K Ghosh, Asoke C Ghose
AFFILIATION: Department of Microbiology, Bose Institute, P-1/12 CIT Scheme
VII-M, Kolkata, 700 054, India.
REFERENCE: Immunol Lett 2003 Apr 86(2):131-8
Intracardial inoculation of BALB/c mice with Leishmania donovani
amastigotes induced progressive visceral leishmaniasis (VL) with
increasing splenic parasite load when followed upto 4-month
postinfection period. In contrast, the liver parasite load reached
maximum around 2-month postinfection period following which it started
declining. The infection pattern differed somewhat from the earlier
reports on mouse model of VL induced by intravenous inoculation of
parasites with respect to the duration as well as magnitude of parasite
burden in the organs (liver and spleen) and associated
hepatosplenomegaly. Immunosuppression in mice with progressive VL was
manifested in the form of impairment of proliferative response of the
splenic mononuclear cells (SPMC) to in vitro stimulation with
leishmanial antigen or the mitogen concanavalin A (ConA), although ConA
stimulated cells were found to be capable of IL-2 and IFN-gamma
synthesis. Differential expression of activating (IL-2, IFN-gamma and
TNF-alpha) as well as deactivating (IL-4 and TGF-beta) cytokines was
demonstrable in the spleen and liver of animals during the course of
infection. Further, the synthesis of inducible nitric oxide synthase (
iNOS) enzyme increased considerably in the liver as well as in the
spleen of 4-month infected animal with parallel increase in the
transcripts of the iNOS activating cytokines IFN-gamma and TNF-alpha.
The temporal variation in the organ specific immune response could be
related to the differential control of parasite burden in the liver and
spleen of the infected host.
PMID: 12695487
TITLE: CD40 signaling is impaired in L. major-infected macrophages and is
rescued by a p38MAPK activator establishing a host-protective memory T cell
response.
AUTHORS: Amit Awasthi, Ramkumar Mathur, Aslam Khan, Bimba N Joshi, Nitya Jain,
Sangeeta Sawant, Ramanamurthy Boppana, Debashis Mitra, Bhaskar Saha
AFFILIATION: National Centre for Cell Science, Ganeshkhind, Pune 411007, India.
REFERENCE: J Exp Med 2003 Apr 197(8):1037-43
Leishmania, a protozoan parasite, lives and multiplies as amastigote
within macrophages. It is proposed that the macrophage expressed CD40
interacts with CD40 ligand on T cells to induce IFN-gamma, a Th1-type
cytokine that restricts the amastigote growth. Here, we demonstrate that
CD40 cross-linking early after infection resulted in inducible nitric
oxide synthetase type-2 (iNOS2) induction and iNOS2-dependent amastigote
elimination. Although CD40 expression remained unaltered on L. major-
infected macrophages, delay in the treatment of macrophages or of mice
with anti-CD40 antibody resulted in significant reduction in iNOS2
expression and leishmanicidal function suggesting impaired CD40
signaling in Leishmania infection. The inhibition of CD40-induced iNOS2
expression by SB203580, a p38-mitogen activated protein kinase (p38MAPK
)-specific inhibitor, and the reversal of the inhibition by anisomycin,
a p38MAPK activator, suggested a crucial role of p38MAPK in CD40
signaling. Indeed, the CD40-induced p38MAPK phosphorylation, iNOS2
expression and anti-leishmanial function were impaired in Leishmania-
infected macrophages but were restored by anisomycin. Anisomycin's
effects were reversed by SB203580 emphasizing the role of p38MAPK in
CD40-induced iNOS2-dependent leishmanicidal function. Anisomycin
administration in L. major-infected BALB/c mice resulted in significant
reduction in the parasite load and established a host-protective Th1-
type memory response. Also implicated in these findings is a scientific
rationale to define novel anti-parasite drug targets and to bypass the
problem of drug resistance.
PMID: 12384497
TITLE: Leishmania EF-1alpha activates the Src homology 2 domain containing
tyrosine phosphatase SHP-1 leading to macrophage deactivation.
AUTHORS: Devki Nandan, Taolin Yi, Martin Lopez, Crystal Lai, Neil E Reiner
AFFILIATION: Department of Medicine, Division of Infectious Diseases, The
University of British Columbia, Research Institute of the Vancouver Hospital
and Health Sciences Center, Vancouver, British Columbia V5Z 3J5, Canada.
dnandan at interchange.ubc.ca
REFERENCE: J Biol Chem 2002 Dec 277(51):50190-7
The human leishmaniasis are persistent infections of macrophages caused
by protozoa of the genus Leishmania. The chronic nature of these
infections is in part related to induction of macrophage deactivation,
linked to activation of the Src homology 2 domain containing tyrosine
phosphatase-1 (SHP-1) in infected cells. To investigate the mechanism of
SHP-1 activation, lysates of Leishmania donovani promastigotes were
subjected to SHP-1 affinity chromatography and proteins bound to the
matrix were sequenced by mass spectrometry. This resulted in the
identification of Leishmania elongation factor-1alpha (EF-1alpha) as a
SHP-1-binding protein. Purified Leishmania EF-1alpha, but not host cell
EF-1alpha, bound directly to SHP-1 in vitro leading to its activation.
Three independent lines of evidence indicated that Leishmania EF-1alpha
may be exported from the phagosome thereby enabling targeting of host
SHP-1. First, cytosolic fractions prepared from macrophages infected
with [(35)S]methionine-labeled organisms contained Leishmania EF-1alpha
. Second, confocal, fluorescence microscopy using Leishmania-specific
antisera detected Leishmania EF-1alpha in the cytosol of infected cells
. Third, co-immunoprecipitation showed that Leishmania EF-1alpha was
associated with SHP-1 in vivo in infected cells. Finally, introduction
of purified Leishmania EF-1alpha, but not the corresponding host protein
into macrophages activated SHP-1 and blocked the induction of inducible
nitric-oxide synthase expression in response to interferon-gamma. Thus
, Leishmania EF-1alpha is identified as a novel SHP-1-binding and
activating protein that recapitulates the deactivated phenotype of
infected macrophages.
PMID: 12555666
TITLE: Control of New World cutaneous leishmaniasis is IL-12 independent but
STAT4 dependent.
AUTHORS: Laurence U Buxbaum, Jude E Uzonna, Michael H Goldschmidt, Phillip
Scott
AFFILIATION: Department of Pathobiology, School of Veterinary Medicine,
University of Pennsylvania, Philadelphia, USA.
REFERENCE: Eur J Immunol 2002 Nov 32(11):3206-15
Leishmania mexicana, a New World protozoan parasite, induces small,
chronic, but non-progressive lesions in C57BL/6 (B6) mice. In this study
we investigated the role of IL-12, and subsequent Th1 factors, in
controlling cutaneous L. mexicana infection. IL-12 treatment failed to
promote disease resolution, suggesting that the inability of mice to
heal is not related to a deficiency of endogenous IL-12 production.
Surprisingly, L. mexicana-induced cutaneous lesions in wild-type and IL-
12p40-deficient mice were indistinguishable, with similar parasite
burdens, immune responses, and lesion histopathology. In contrast, iNOS
, IFN-gamma, and STAT4-deficient mice developed progressive disease and
uncontrolled parasite growth. These results differ dramatically from L.
major infection, in which IL-12p40-deficient mice are highly susceptible
, with very rapid lesion growth, very large parasite burdens, and the
development of a strong Th2 response. These data uncover the existence
of an alternate IFN-gamma and iNOS pathway for control of Leishmania
lesions, which is IL-12 independent, but which unexpectedly requires
STAT4.
PMID: 12379707
TITLE: Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10
receptor blockade as immunotherapy.
AUTHORS: Henry W Murray, Christina M Lu, Smita Mauze, Sherry Freeman, Andre L
Moreira, Gilla Kaplan, Robert L Coffman
AFFILIATION: Department of Medicine, Weill Medical College of Cornell
University, New York, New York 10021, USA. hwmurry at med.cornell.edu
REFERENCE: Infect Immun 2002 Nov 70(11):6284-93
Interleukin-10 (IL-10) is thought to promote intracellular infection,
including human visceral leishmaniasis, by disabling Th1 cell-type
responses and/or deactivating parasitized tissue macrophages. To develop
a rationale for IL-10 inhibition as treatment in visceral infection,
Th1 cytokine-driven responses were characterized in Leishmania donovani-
infected BALB/c mice in which IL-10 was absent or overexpressed or its
receptor (IL-10R) was blockaded. IL-10 knockout and normal mice treated
prophylactically with anti-IL-10R demonstrated accelerated granuloma
assembly and rapid parasite killing without untoward tissue inflammation
; IL-12 and gamma interferon mRNA expression, inducible nitric oxide
synthase reactivity, and responsiveness to antimony chemotherapy were
also enhanced in knockout mice. In IL-10 transgenic mice, parasite
replication was unrestrained, and except for antimony responsiveness,
measured Th1 cell-dependent events were all initially impaired. Despite
subsequent granuloma assembly, high-level infection persisted, and
antimony-treated transgenic mice also relapsed. In normal mice with
established infection, anti-IL-10R treatment was remarkably active,
inducing near-cure by itself and synergism with antimony. IL-10's
deactivating effects regulate outcome in experimental visceral
leishmaniasis, and IL-10R blockade represents a potential immuno- and/or
immunochemotherapeutic approach in this infection.
PMID: 12443660
TITLE: Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against
murine visceral leishmaniasis.
AUTHORS: Wania Renata Santos, Valeria M F de Lima, Edilma Paraguai de Souza,
Robson Ronney Bernardo, Marcos Palatnik, Clarisa Beatriz Palatnik de Sousa
AFFILIATION: Instituto de Microbiologia, "Professor Paulo de Góes" Universidade
Federal do Rio de Janeiro (UFRJ), CCS, Cidade Universitária, Ilha do Fundão,
Caixa Postal 68040, CEP 21941-590, RJ, Rio de Janeiro, Brazil.
REFERENCE: Vaccine 2002 Nov 21(1-2):30-43
The FML antigen of Leishmania donovani, in combination with either
Riedel de Haën (R), QuilA, QS21 saponins, IL12 or BCG, was used in
vaccination of an outbred murine model against visceral leishmaniasis (
VL). Significant and specific increases in anti-FML IgG and IgM
responses were detected for all adjuvants, and in anti-FML IgG1, IgG2a
and IgG2b and delayed type of hypersensitivity to L. donovani lysate (
DTH), only for all saponins and IL12. The QS21-FML and QuilA-FML groups
achieved the highest IgG2a response. QuilA-FML developed the strongest
DTH and QS21-FML animals showed the highest serum IFN-gamma
concentrations. The reduction of parasitic load in the liver in response
to each FML-vaccine formulation was: 52% (P<0.025) for BCG-FML, 73
% (P<0.005) for R-FML, 93% (P<0.005) for QuilA-FML and 79.2% (P<
;0.025) for QS21-FML treated animals, respectively. Protection was
specific for R-FML and QS21-FML while the QuilA saponin treatment itself
induced 69% of LDU reduction. The FML-saponin vaccines promote
significant, specific and strong protective effects against murine
visceral leishmaniasis. BCG-FML induced minor and non-specific
protection while IL12-FML, although enhancing the specific antibody and
IDR response, failed to reduce the parasitic load of infected animals.
PMID: 12471424
TITLE: B-cell infiltration and frequency of cytokine producing cells differ
between localized and disseminated human cutaneous leishmaniases.
AUTHORS: M G S Vieira, F Oliveira, S Arruda, A L Bittencourt, A A Barbosa, M
Barral-Netto, A Barral
AFFILIATION: Faculdade de Medicina, Universidade Federal da Bahias, Salvador,
BA, Brasil.
REFERENCE: Mem Inst Oswaldo Cruz 2002 Oct 97(7):979-83
Biopsies from human localized cutaneous lesions (LCL n = 7) or
disseminated lesions (DL n = 8) cases were characterized according to
cellular infiltration,frequency of cytokine (IFN-gamma, TNF-alpha) or
iNOS enzyme producing cells. LCL, the most usual form of the disease
with usually one or two lesions, exhibits extensive tissue damage. DL is
a rare form with widespread lesions throughout the body; exhibiting
poor parasite containment but less tissue damage. We demonstrated that
LCL lesions exhibit higher frequency of B lymphocytes and a higher
intensity of IFN-gamma expression. In both forms of the disease CD8+
were found in higher frequency than CD4+ T cells. Frequency of TNF-alpha
and iNOS producing cells, as well as the frequency of CD68+ macrophages
, did not differ between LCL and DL. Our findings reinforce the link
between an efficient control of parasite and tissue damage, implicating
higher frequency of IFN-gamma producing cells, as well as its possible
counteraction by infiltrated B cells and hence possible humoral immune
response in situ.
PMID: 12183555
TITLE: Endogenous interleukin-12 is critical for controlling the late but not
the early stage of Leishmania mexicana infection in C57BL/6 mice.
AUTHORS: Fabiola Aguilar Torrentera, Jon D Laman, Marjan Van Meurs, Luciano
Adorini, Eric Muraille, Y Carlier
AFFILIATION: Laboratory of Parasitology, Free University of Brussels (ULB),
Brussels, Belgium.
REFERENCE: Infect Immun 2002 Sep 70(9):5075-80
The role of interleukin-12 (IL-12) has been clearly established in the
resistance of C57BL/6 (B6) mice to Leishmania major infection, but its
involvement in the control of Leishmania mexicana infection remains to
be determined. Here, we show the following. (i) L. mexicana, in contrast
to L. major, induces the development of nonhealing lesions in B6 mice
. (ii) Cells expressing IL-12p40, gamma interferon (IFN-gamma), NOS2,
and CD40L are numerous in the footpad lesion and/or the draining
popliteal lymph node of animals infected for up to 14 weeks with L.
mexicana. (iii) B6 mice, either IL-12p40 deficient or treated with IL-
12p40-neutralizing antibodies, display a dramatic enhancement of primary
and secondary lesions leading to death 10 weeks after inoculation with
L. mexicana. (iv) Splenocytes harvested 4 and 8 weeks after infection of
IL-12p40(-/-) B6 mice with L. mexicana are unable to produce IFN-gamma
, but secrete IL-4, IL-10, and IL-18. Thus, the early control of L.
mexicana infection by B6 mice is independent of IL-12, whereas IL-12 and
Th1 responses play a key role in controlling the late stages of L.
mexicana infection. However, they fail to resolve lesions, in contrast
to L. major infection, emphasizing the different outcomes induced by
these two Leishmania species in B6 mice.
PMID: 12117977
TITLE: Expression of inducible nitric oxide synthase in skin lesions of patients
with american cutaneous leishmaniasis.
AUTHORS: Muna Qadoumi, Inge Becker, Norbert Donhauser, Martin Röllinghoff,
Christian Bogdan
AFFILIATION: Institute of Clinical Microbiology, Immunology and Hygiene,
University of Erlangen, Germany.
REFERENCE: Infect Immun 2002 Aug 70(8):4638-42
Cytokine-inducible (or type 2) nitric oxide synthase (iNOS) is
indispensable for the resolution of Leishmania major or Leishmania
donovani infections in mice. In contrast, little is known about the
expression and function of iNOS in human leishmaniasis. Here, we show by
immunohistological analysis of skin biopsies from Mexican patients with
local (LCL) or diffuse (DCL) cutaneous leishmaniasis that the
expression of iNOS was most prominent in LCL lesions with small numbers
of parasites whereas lesions with a high parasite burden (LCL or DCL)
contained considerably fewer iNOS-positive cells. This is the first
study to suggest an antileishmanial function of iNOS in human Leishmania
infections in vivo.
PMID: 11895981
TITLE: Early enhanced Th1 response after Leishmania amazonensis infection of
C57BL/6 interleukin-10-deficient mice does not lead to resolution of
infection.
AUTHORS: Douglas E Jones, Mark R Ackermann, Ulrike Wille, Christopher A Hunter,
Phillip Scott
AFFILIATION: Department of Veterinary Pathology, College of Veterinary Medicine,
Iowa State University, Ames, Iowa 50011, USA. jonesdou at iastate.edu
REFERENCE: Infect Immun 2002 Apr 70(4):2151-8
C3H and C57BL/6 mice are resistant to Leishmania major but develop
chronic lesions with persistent parasite loads when they are infected
with Leishmania amazonensis. These lesions develop in the absence of
interleukin-4 (IL-4), indicating that susceptibility to this parasite is
not a result of development of a Th2 response. Expression of the
cytokine IL-10 during infection could account for the lack of IL-12
expression and poor cell-mediated immunity towards the parasite.
Therefore, we tested the hypothesis that IL-10 plays a central role in
downmodulating the Th1 response after L. amazonensis infection.
Infection of C57BL/6 IL-10-deficient mice indicated that in the absence
of IL-10 there was early enhancement of a Th1 response, which was
downregulated during the more chronic stage of infection. In addition,
although there were 1- to 2-log reductions in the parasite loads within
the lesions, the parasites continued to persist, and they were
associated with chronic lesions whose size was similar to that of the
control lesions. These experiments indicated that L. amazonensis
resistance to killing in vivo is only partially dependent on expression
of host IL-10. However, IL-10-deficient mice had an enhanced delayed-
type hypersensitivity response during the chronic phase of infection,
indicating that there were Th1 type effector cells in vivo at this late
stage of infection. These results indicate that although IL-10 plays a
role in limiting the Th1 response during the acute infection phase,
other immunomodulatory factors are responsible for limiting the Th1
response during the chronic phase.
PMID: 11985871
TITLE: Detection of iNOS gene expression in cutaneous leishmaniasis biopsy
tissue.
AUTHORS: Iracema Arevalo, Brian Ward, Greg Matlashewski
AFFILIATION: Department of Microbiology and Immunology, McGill University,
Montreal, Que., Canada.
REFERENCE: Mol Biochem Parasitol 2002 Apr 121(1):145-7
PMID: 11825771
TITLE: Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis
in host macrophages.
AUTHORS: Filomena M Perrella Balestieri, Allan R Pires Queiroz, Cristoforo
Scavone, Vlaudia M Assis Costa, Manoel Barral-Netto, Ises de Almeida
Abrahamsohn
AFFILIATION: Departamento de Fisiologia e Patologia/Laboratório de Tecnologia
Farmacêutica, UFPB, João Pessoa, CEP 58051-970, PB, Brazil.
REFERENCE: Microbes Infect 2002 Jan 4(1):23-9
Inhibition of lipopolysaccharide (LPS)-induced nitric oxide (NO)
production was demonstrated in J774-G8 macrophages infected with
Leishmania (L.) amazonensis promastigotes. The downmodulation of NO
production observed in infected and LPS-stimulated J774-G8 cells
correlated with a reduction in inducible nitric oxide synthase (iNOS)
activity. Reduction in iNOS activity was not paralleled by decreased
iNOS mRNA expression, suggesting that the parasite affects post-
transcriptional events of NO synthesis. Supplementation with L-arginine
or tetrahydrobiopterin did not increase NO production, suggesting that
inhibition is not due to an insufficiency of substrate or co-factor.
Treatment with anti-IL-10, anti-IL-4 or anti-TGF-beta neutralizing
antibodies also failed to increase NO production, indicating that these
cytokines are not involved in the observed parasite-induced inhibition
of NO synthesis. However, treatment of the cultures with IFN-gamma
resulted in a marked increase in NO production by infected LPS-
stimulated cells. These results show that although L.(L.) amazonensis
infection inhibits iNOS activity and NO production by J774-G8 cells,
activation by IFN-gamma is capable of overriding the suppression of NO
synthesis.
PMID: 12078472
TITLE: Nitric oxide production by Leishmania-infected macrophages and modulation
by cytokines and prostaglandins.
AUTHORS: O Brandonisio, M A Panaro, M Sisto, A Acquafredda, L Fumarola, D
Leogrande, V Mitolo
AFFILIATION: Dipartimento di Clinica Medica, Immunologia e Malattie Infettive,
Sezione di Microbiologia ed Immunologia, Facoltà di Medicina e Chirurgia,
Università di Bari, Policlinico, Piazza G. Cesare, 70124 Bari, Italy.
brandoni at cimedoc.uniba.it
REFERENCE: Parassitologia 2001 Dec 43 Suppl 1():1-6
Nitric oxide (NO) produced by an inducible nitric oxide synthase (iNOS
or NOS2) plays a major microbicidal role in murine macrophages and its
importance is now emerging also in the dog and human models. In dogs we
demonstrated that macrophages in vitro infected with Leishmania infantum
produced NO, after stimulation with cytokine-enriched peripheral blood
mononuclear cell supernatants. In addition, parasite killing was reduced
by the NOS inhibitor L-NG monomethylarginine. On the contrary, canine
blood monocytes before macrophage differentiation did not release NO,
and their leishmanicidal activity was instead correlated with superoxide
anion and interferon (IFN)-gamma production. In human macrophage
cultures, after infection with Leishmania infantum, we showed both iNOS
expression by immunofluorescence and western blotting and NO release by
the Griess reaction for nitrites. Various cytokines and prostaglandins
can differently modulate NO synthesis. In our experiments, stimulation
by recombinant human IFN-gamma and bacterial lipopolysaccharide greatly
enhanced iNOS expression and NO production in human macrophages. In
addition, the prostaglandin E2 increased NO release in activated,
Leishmania-infected human macrophages. These results are interesting in
the light of a possible immunological or pharmacological regulation of
NO synthesis and microbicidal functions of macrophages.
PMID: 11592059
TITLE: IL-10 mediates susceptibility to Leishmania donovani infection.
AUTHORS: M L Murphy, U Wille, E N Villegas, C A Hunter, J P Farrell
AFFILIATION: Department of Pathobiology, School of Veterinary Medicine,
University of Pennsylvania, Philadelphia 19104, USA.
REFERENCE: Eur J Immunol 2001 Oct 31(10):2848-56
Human visceral leishmaniasis (VL) results in a severe and potentially
fatal systemic disease, accompanied by cellular immune depression. The
production of IL-10 correlates with ongoing disease and it has been
suggested that the cellular immune depression that accompanies active
disease may be due to a predominance of IL-10 production rather than a
lack of IFN-gamma production, which is essential for optimal macrophage
activation and parasite elimination. To examine the role of IL-10 in
resistance during L. donovani infection (a causative agent of VL), the
course of infection was examined in mice lacking the gene for IL-10.
BALB/c IL-10-/-, as well as C57BL/6 IL-10-/- mice, were highly resistant
to L. donovani infection, as evidenced by liver parasite burdens which
were tenfold lower than those in control mice after 14 days of infection
. Enhanced resistance was accompanied by increased production of IFN-
gamma and nitric oxide in BALB/c IL-10-/- mice. Susceptibility to
infection in BALB/c IL-10-/- mice was enhanced following in vivo
treatment with a neutralizing antibody to IFN-gamma or IL-12. Together
these studies demonstrate for the first time that IL-10 is a critical
component of the immune response that inhibits resistance to L. donovani.
PMID: 11561959
TITLE: Inducible nitric oxide synthase expression in Leishmania-infected dog
macrophages.
AUTHORS: M Sisto, O Brandonisio, M A Panaro, A Acquafredda, D Leogrande, A
Fasanella, T Trotta, L Fumarola, V Mitolo
AFFILIATION: Dipartimento di Clinica Medica, Immunologia e Malattie Infettiva e
Sezione di Microbiologia e Immunologia, University of Bari, Italy.
REFERENCE: Comp Immunol Microbiol Infect Dis 2001 Oct 24(4):247-54
Nitric oxide (NO) production by the inducible NO synthase (iNOS or NOS2
) represents one of the main microbicidal mechanisms of murine
macrophages, but its role in other animal models is poorly investigated
. Therefore, the aim of this work was to evaluate NOS2 expression in dog
macrophages infected with Leishmania infantum. Macrophages obtained
from peripheral blood of healthy dogs were activated with recombinant
human interferon (rhIFN)-gamma and bacterial lipopolysaccharide (LPS)
and then infected with L. infantum promastigotes. zymodeme MONI. For the
immunofluorescence assay fixed macrophages were incubated with
polyclonal rabbit anti-NOS2 and then with rhodamine F(ab')2 goat anti-
rabbit IgG. For immunoblotting, cell lysates were submitted to SDS-PAGE
and blots were incubated with polyclonal rabbit anti-NOS2 and then with
horseradish peroxidase-conjugated goat anti-rabbit IgG. Results
demonstrated that L. infantum-infected cells, after stimulation with
rhIFN-gamma and LPS, displayed high levels of fluorescence for the NOS2
in their cytoplasm, unlike unstimulated uninfected macrophages. In
western blotting, polyclonal anti-NOS2 reacted specifically with a
protein band corresponding to 130 kDa. The signal produced in Leishmania
-infected cells stimulated with rhIFN-gamma and LPS was higher than that
produced in Leishmania-infected unstimulated cells. No band was
detected in cellular lysates from uninfected unstimulated cells. These
results indicate that dog macrophages can express NOS2, and suggest a
role for IFN-gamma and LPS in NOS2 induction also in this animal model.
PMID: 11447142
TITLE: Malnutrition alters the innate immune response and increases early
visceralization following Leishmania donovani infection.
AUTHORS: G M Anstead, B Chandrasekar, W Zhao, J Yang, L E Perez, P C Melby
AFFILIATION: Medical Service, Department of Veterans Affairs Medical Center,
South Texas Veterans Health Care System, University of Texas Health Science
Center at San Antonio, San Antonio, Texas 78229-3900, USA.
REFERENCE: Infect Immun 2001 Aug 69(8):4709-18
Malnutrition is a risk factor for the development of visceral
leishmaniasis. However, the immunological basis for this susceptibility
is unknown. We have developed a mouse model to study the effect of
malnutrition on innate immunity and early visceralization following
Leishmania donovani infection. Three deficient diets were studied,
including 6, 3, or 1% protein; these diets were also deficient in iron,
zinc, and calories. The control diet contained 17% protein, was zinc and
iron sufficient, and was provided ab libitum. Three days after
infection with L. donovani promastigotes, the total extradermal (lymph
nodes, liver, and spleen) and skin parasite burdens were equivalent in
the malnourished (3% protein) and control mice, but in the malnourished
group, a greater percentage (39.8 and 4.0%, respectively; P = 0.009) of
the extradermal parasite burden was contained in the spleen and liver.
The comparable levels of parasites in the footpads in the two diet
groups and the higher lymph node parasite burdens in the well-nourished
mice indicated that the higher visceral parasite burdens in the
malnourished mice were not due to a deficit in local parasite killing
but to a failure of lymph node barrier function. Lymph node cells from
the malnourished, infected mice produced increased levels of
prostaglandin E(2) (PGE(2)) and decreased levels of interleukin-10.
Inducible nitric oxide synthase activity was significantly lower in the
spleen and liver of the malnourished mice. Thus, malnutrition causes a
failure of lymph node barrier function after L. donovani infection,
which may be related to excessive production of PGE(2) and decreased
levels of IL-10 and nitric oxide.
PMID: 11441096
TITLE: Oxidative responses of human and murine macrophages during phagocytosis
of Leishmania chagasi.
AUTHORS: K R Gantt, T L Goldman, M L McCormick, M A Miller, S M Jeronimo, E T
Nascimento, B E Britigan, M E Wilson
AFFILIATION: Immunology Program, Department of Internal Medicine, University of
Iowa, Iowa City, IA 52242, USA.
REFERENCE: J Immunol 2001 Jul 167(2):893-901
Leishmania chagasi, the cause of South American visceral leishmaniasis,
must survive antimicrobial responses of host macrophages to establish
infection. Macrophage oxidative responses have been shown to diminish in
the presence of intracellular leishmania. However, using electron spin
resonance we demonstrated that murine and human macrophages produce O2-
during phagocytosis of opsonized promastigotes. Addition of the O2-
scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl to cultures
resulted in increased infection, suggesting that O2- enhances macrophage
leishmanicidal activity. The importance of NO. produced by inducible NO
synthase (iNOS) in controlling murine leishmaniasis is established, but
its role in human macrophages has been debated. We detected NO. in
supernatants from murine, but not human, macrophages infected with L.
chagasi. Nonetheless, the iNOS inhibitor N(G)-monomethyl-L-arginine
inhibited IFN-gamma-mediated intracellular killing by both murine and
human macrophages. According to RNase protection assay and
immunohistochemistry, iNOS mRNA and protein were expressed at higher
levels in bone marrow of patients with visceral leishmaniasis than in
controls. The iNOS protein also increased upon infection of human
macrophages with L. chagasi promastigotes in vitro in the presence of
IFN-gamma. These data suggest that O2- and NO. each contribute to
intracellular killing of L. chagasi in human and murine macrophages.
PMID: 11378016
TITLE: Th1/Th2-regulated arginase availability modulates Leishmania infection.
AUTHORS: A Taylor-Robinson
REFERENCE: Trends Parasitol 2001 Jun 17(6):262
PMID: 11368921
TITLE: Role of peroxynitrite in macrophage microbicidal mechanisms in vivo
revealed by protein nitration and hydroxylation.
AUTHORS: E Linares, S Giorgio, R A Mortara, C X Santos, A T Yamada, O Augusto
AFFILIATION: Departamento de BioquÃmica, Instituto de QuÃmica, Universidade de
São Paulo, São Paulo, Brazil.
REFERENCE: Free Radic Biol Med 2001 Jun 30(11):1234-42
The cytotoxins produced by phagocytic cells lacking peroxidases such as
macrophages remain elusive. To elucidate macrophage microbicidal
mechanisms in vivo, we compared the lesion tissue responses of resistant
(C57Bl/6) and susceptible (BALB/c) mice to Leishmania amazonensis
infection. This comparison demonstrated that parasite control relied on
lesion macrophage activation with inducible nitric oxide synthase
expression (iNOS), nitric oxide synthesis, and extensive nitration of
parasites inside macrophage phagolysosomes at an early infection stage.
Nitration and iNOS expression were monitored by confocal microscopy;
nitric oxide synthesis was monitored by EPR. The main macrophage
nitrating agent was shown to be peroxynitrite derived because parasite
nitration occurred in the virtual absence of polymorphonuclear cells (
monitored as peroxidase activity) and was accompanied by protein
hydroxylation (monitored as 3-hydroxytyrosine levels). In vitro studies
confirmed that peroxynitrite is cytotoxic to parasites whereas nitric
oxide is cytostatic. The results indicate that peroxynitrite is likely
to be produced close to the parasites and most of it reacts with carbon
dioxide to produce carbonate radical anion and nitrogen dioxide whose
concerted action leads to parasite nitration. In parallel, some
peroxynitrite decomposition to the hydroxyl radical should occur due to
the detection of hydroxylated proteins in the healing tissues.
Consequently, peroxynitrite and derived radicals are likely to be
important macrophage-derived cytotoxins.
PMID: 11298294
TITLE: Leishmania donovani-induced macrophages cyclooxygenase-2 and
prostaglandin E2 synthesis.
AUTHORS: C Matte, G Maion, W Mourad, M Olivier
AFFILIATION: Centre de Recherche en Infectiologie, Université Laval, Ste-Foy,
Québec, Canada. Centre de Rhumatologie et Immunologie du CHUL, Université
Laval, Ste-Foy, Québec, Canada.
REFERENCE: Parasite Immunol 2001 Apr 23(4):177-84
Prostaglandin E2 (PGE2) secretion during Leishmania infection has been
reported. However, the signalling mechanisms mediating this response are
not well understood. Since cyclooxygenase-2 (COX-2) and cytosolic
phospholipase A2 (cPLA2) are involved in PGE2 synthesis in response to
various stimuli, the implication of these enzymes was evaluated in
Leishmania-infected phorbol myristate acetate-differentiated U937 human
monocytic cell line. Time-course experiments showed that PGE2 synthesis
increased significantly in parallel with COX-2 expression when cells
were incubated in the presence of Leishmania donovani promastigotes or
lipopolysaccharides (LPS). Increase in cPLA2 mRNA expression was only
detected when cells were stimulated with LPS. Indomethacin, genistein,
and H7, which are antagonists of COX-2, protein tyrosine kinase (PTK)
and protein kinase C (PKC), respectively, inhibited PGE2 production
induced by L. donovani and LPS. However, only H7 inhibited COX-2 mRNA
synthesis, and there was a significant correlation between PGE2
inhibition and reduced COX-2 expression. Collectively, our results
indicate that infection of U937 by L. donovani leads to the generation
of PGE2 in part through a PKC-dependent signalling pathway involving COX
-2 expression. They further reveal that PTK-dependent events are
necessary for Leishmania-induced PGE2 generation, but not for COX-2
expression. A better understanding of the mechanisms by which Leishmania
can induce PGE2 production could provide insight into the
pathophysiology of leishmaniasis and may help to improve therapeutic
approaches.
PMID: 11257027
TITLE: Identification of genes induced by a macrophage activator, S-28463, using
gene expression array analysis.
AUTHORS: S Buates, G Matlashewski
AFFILIATION: Department of Microbiology and Immunology, McGill University,
Montreal, Canada H3A 2B4.
REFERENCE: Antimicrob Agents Chemother 2001 Apr 45(4):1137-42
S-28463 and imiquimod are imidazoquinoline compounds which stimulate
microbicidal activity by inducing a local immune response at the site of
application. Imiquimod-containing cream is an effective clinical
treatment against cervical warts caused by human papillomavirus
infection. Imiquimod also induces leishmanicidal activity both in vitro
in macrophages and in vivo in a mouse model for cutaneous leishmaniasis
. The major target cells of S-28463 and imiquimod are macrophages. To
explore the molecular basis in which imidazoquinolines generate
macrophage microbicidal activity, a cDNA gene array analysis was
undertaken to identify genes induced by S-28463. Out of 588 genes
screened in this assay, only 13 genes were significantly induced by S-
28463. Remarkably, virtually all of the induced genes are involved in
macrophage activation and inflammatory response. This experimental
approach defines the mechanism of action of this clinically relevant
compound in the induction of microbicidal activity in macrophages and
also potentially identifies novel genes associated with microbicidal
activity in this cell type.
PMID: 11238648
TITLE: Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF.
AUTHORS: P Wilhelm, U Ritter, S Labbow, N Donhauser, M Röllinghoff, C Bogdan, H
Körner
AFFILIATION: Institut für Klinische Mikrobiologie, Immunologie, Universität
Erlangen-Nürnberg, Erlangen, Germany.
REFERENCE: J Immunol 2001 Mar 166(6):4012-9
The resolution of infections with the protozoan parasite Leishmania
major in mice requires a Th1 response that is closely associated with
the expression of IL-12, IFN-gamma, and inducible NO synthase. Previous
Ab neutralization studies or the use of mice deficient for both TNF
receptors suggested that TNF plays only a limited role in the control of
parasite replication in vivo. In this study we demonstrate that
resistant C57BL/6 (B6.WT) mice locally infected with L. major rapidly
succumb to progressive visceral leishmaniasis after deletion of the TNF
gene by homologous recombination. A reduction of the parasite inoculum
to 3000 promastigotes did not prevent the fatal outcome of the disease.
An influence of the altered morphology of secondary lymphoid organs in
C57BL/6-TNF(-/-) (B6.TNF(-/-)) mice on the course of disease could be
excluded by the generation of reciprocal bone marrow chimeras. Although
infected B6.TNF(-/-) mice mounted an L. major-specific IFN-gamma
response and expressed IL-12, the onset of the immune reaction was
delayed. After in vitro stimulation, B6.TNF(-/-) inflammatory
macrophages released 10-fold less NO in response to IFN-gamma than B6.WT
cells. However, in the presence of a costimulus, e.g., L. major
infection or LPS, the production of NO by B6.WT and B6.TNF(-/-)
macrophages was comparable. In vivo, inducible NO synthase protein was
readily detectable in skin lesions and draining lymph nodes of B6.TNF
(-/-) mice, but its expression was more disperse and less focal in the
absence of TNF. These are the first data to demonstrate that TNF is
essential for the in vivo control of L. major.
PMID: 11159954
TITLE: Pretreatment with recombinant Flt3 ligand partially protects against
progressive cutaneous leishmaniasis in susceptible BALB/c mice.
AUTHORS: I B Kremer, M P Gould, K D Cooper, F P Heinzel
AFFILIATION: Department of Dermatology, University Hospitals of Cleveland,
Cleveland, Ohio 44106, USA.
REFERENCE: Infect Immun 2001 Feb 69(2):673-80
Dendritic cells are potent antigen-presenting cells that also produce
interleukin-12 (IL-12) during innate and adaptive cellular immune
responses and that thereby promote the differentiation of gamma
interferon (IFN-gamma)-producing Th1-type CD4(+) T lymphocytes. We
hypothesized that expanded dendritic-cell populations in mice pretreated
with the hematopoietic cytokine Flt3L would protect against cutaneous
Leishmania major infection. Pretreatment of disease-susceptible BALB/c
mice with 10 microg of recombinant Flt3L (rFlt3L) for 9 to 10 days
before infection increased lymph node IL-12 p40 productive capacity 20-
fold compared to that of saline-injected controls. Furthermore, 9 of 22
(40.9%) rFlt3L-pretreated BALB/c mice resolved their cutaneous
infections, whereas none of the 22 control BALB/c mice healed. Healed,
rFlt3L-pretreated mice did not develop disease following reinfection.
Flt3L pretreatment also reduced parasite numbers 1,000-fold in the
cutaneous lesions at 2 weeks after infection relative to numbers in
lesions of untreated controls. However, Flt3L pretreatment did not
significantly alter L. major-induced IFN-gamma and IL-4 production in
lymph node culture at 1, 2, and 4 weeks after infection. Despite the
lack of Th immune deviation, Flt3L ligand-pretreated lymph nodes
expressed up to 10-fold higher levels of IL-12 p40 and inducible (type 2
) nitric oxide synthase mRNA at 7 days after infection. In contrast,
treatment with rFlt3L after infection failed to protect against disease
despite comparable expansions of dendritic cells and IL-12 p40
productive capacity in both infected and uninfected BALB/c mice treated
with rFlt3L. We conclude that rFlt3L pretreatment before infection with
L. major reduces parasite load and promotes healing of cutaneous lesions
without stable cytokine deviation towards a dominant Th1 cytokine
phenotype.
PMID: 11160239
TITLE: The hamster as a model of human visceral leishmaniasis: progressive
disease and impaired generation of nitric oxide in the face of a prominent
Th1-like cytokine response.
AUTHORS: P C Melby, B Chandrasekar, W Zhao, J E Coe
AFFILIATION: Medical Service, Department of Veterans Affairs Medical Center,
South Texas Veterans Health Care System, San Antonio, TX 78284, USA.
melby at uthscsa.edu
REFERENCE: J Immunol 2001 Feb 166(3):1912-20
Active human visceral leishmaniasis (VL) is characterized by a
progressive increase in visceral parasite burden, cachexia, massive
splenomegaly, and hypergammaglobulinemia. In contrast, mice infected
with Leishmania donovani, the most commonly studied model of VL, do not
develop overt, progressive disease. Furthermore, mice control Leishmania
infection through the generation of NO, an effector mechanism that does
not have a clear role in human macrophage antimicrobial function.
Remarkably, infection of the Syrian hamster (Mesocricetus auratus) with
L. donovani reproduced the clinicopathological features of human VL, and
investigation into the mechanisms of disease in the hamster revealed
striking differences from the murine model. Uncontrolled parasite
replication in the hamster liver, spleen, and bone marrow occurred
despite a strong Th1-like cytokine (IL-2, IFN-gamma, and TNF/lymphotoxin
) response in these organs, suggesting impairment of macrophage effector
function. Indeed, throughout the course of infection, inducible NO
synthase (iNOS, NOS2) mRNA or enzyme activity in liver or spleen tissue
was not detected. In contrast, NOS2 mRNA and enzyme activity was readily
detected in the spleens of infected mice. The impaired hamster NOS2
expression could not be explained by an absence of the NOS2 gene,
overproduction of IL-4, defective TNF/lymphotoxin production (a potent
second signal for NOS2 induction), or early dominant production of the
deactivating cytokines IL-10 and TGF-beta. Thus, although a Th1-like
cytokine response was prominent, the major antileishmanial effector
mechanism that is responsible for control of infection in mice was
absent throughout the course of progressive VL in the hamster.
PMID: 11421463
TITLE: Tannins and related compounds: killing of amastigotes of Leishmania
donovani and release of nitric oxide and tumour necrosis factor alpha in
macrophages in vitro.
AUTHORS: A F Kiderlen, O Kayser, D Ferreira, H Kolodziej
AFFILIATION: Robert Koch-Institut, Abteilung für Infektionskrankheiten, Berlin,
Germany.
REFERENCE: Z Naturforsch [C] 2001 May-Jun 56(5-6):444-54
The antileishmanial and immunomodulatory potencies of a series of 28
polyphenols were evaluated in terms of extra- and intracellular
leishmanicidal activity and macrophage activation for release of nitric
oxide (NO), tumour necrosis factor (TNF) and interferon (IFN)-like
properties. For this, several functional bioassays were employed
including an in vitro model for leishmaniasis in which murine bone
marrow-derived macrophages (BMMphi) were infected with the obligate
intracellular parasite Leishmania donovani, an extracellular Leishmania
proliferation assay, a fibroblast-lysis assay (TNF-activity), and a
biochemical assay for NO. Except for gallic acid, its methyl ester,
shikimic acid and catechin (EC50 25.8-67.9 nM) all polyphenols tested
significantly inhibited the intracellular survival of L. donovani
amastigotes (EC50 0.4-13.9 nM) when compared with the clinically used
agent, sodium stibogluconate (EC50 10.6 nM). In contrast, none of the
samples proved to be directly toxic for the extracellular promastigote
form of the parasite. Noteworthy, the phenolic samples showed only
moderate or no cytotoxicity against the murine host cells (EC50 10 to >
144 nM). Although NO is an important effector molecule in macrophage
microbicidal activity, the inducing potential of the test compounds for
its release was found to be very moderate ranging from 7-54 microM (IFN-
gamma/LPS 119 microM). On the other hand, inhibition of NO production
had no apparent effect on intracellular leishmanicidal activity of
polyphenols. Their in vitro TNF-inducing potential producing 50% lysis
in murine L929 cells increased in the order of simple phenols and
flavanols (34-48 U/ml) < A-type proanthocyanidins (53-80 U/ml) < B
-type proanthocyanidins (64-200 U/ml) < hydrolyzable tannins (287-350
U/ml) at the host cell subtoxic concentration of 50 microg/ml.
Furthermore, gallic acid and some hydrolyzable tannins showed
appreciable IFN-like activities (14-23 U/ml) as reflected by inhibition
of the cytopathic effect of encephalomyocarditis virus on fibroblast L
929 cells. The results provide a rational basis for the recorded anti-
infectious efficacy of traditionally used herbal medicines containing
tannins in vivo, in the light of both only moderate direct antimicrobial
activities of distinct polyphenols in vitro and the limited knowledge
on their uptake in humans.
PMID: 11399524
TITLE: Sustained parasite burden in the spleen of Leishmania infantum-infected
BALB/c mice is accompanied by expression of MCP-1 transcripts and lack of
protection against challenge.
AUTHORS: D Rousseau, S Demartino, F Anjuère, B Ferrua, K Fragaki, Y Le Fichoux,
J Kubar
AFFILIATION: Groupe de Recherche en Immunopathologie de la Leishmaniose (EA
2675), Laboratoire de Parasitologie, Faculté de Médecine, avenue de
Valombrose, 06107 Nice Cedex 2, France.
REFERENCE: Eur Cytokine Netw 2001 Apr-Jun 12(2):340-7
We analyzed differential responses of spleen and liver, major organ
targets for viscerotropic Leishmania species, to experimental infection
and examined if resistance to challenge was organ-specific. In liver,
parasites were spontaneously cleared and iNOS trancripts expression
paralleled that of amastigote load. In the spleen, amastigote
multiplication was only partly controlled, and iNOS transcripts
expression was transient. Total numbers of spleen cells, B cells, and T
cells were decreased, while F4/80(+) and Mac1(+) cells were conserved.
Expression of splenic MCP-1 transcripts remained constant, indicating
its possible contribution to immigration of Leishmania host cells and to
sustained parasite load. Spleen cells produced both, Th1- and Th2-type
cytokines and Th2-type response was dominant, compatible with the
sustained MCP-1 expression. Challenge experiments showed that in
contrast to the liver, where initial infection conferred a progressively
established immunity, in the spleen there was no induced protection
against reinfection. Organ-specific resistance against challenge could
be important for designing antileishmanial vaccines.
PMID: 11169417
TITLE: The outcome of Leishmania major experimental infection in BALB/c mice can
be modulated by exogenously delivered iron.
AUTHORS: S Bisti, G Konidou, F Papageorgiou, G Milon, J R Boelaert, K
Soteriadou
AFFILIATION: Department of Biochemistry, Laboratory of Molecular Parasitology,
Hellenic Pasteur Institute, Athens, Greece.
REFERENCE: Eur J Immunol 2000 Dec 30(12):3732-40
We previously established that Leishmania promastigotes express a
transferrin receptor and that iron chelators inhibit promastigote growth
in vitro. Thus, we were interested in modulating the vertebrate host
iron pool and to monitor whether such changes will affect the outcome of
L. major infection in BALB / c mice, inoculated in the footpad with 106
stationary phase promastigotes. Treatment of mice with desferrioxamine
resulted in a slight delay of the development of cutaneous lesions. In
contrast and unexpectedly, systemic iron delivery, at early time points
of parasite delivery, significantly limited footpad pathology.
Accordingly, parasite loads at the site of parasite delivery, the
draining lymph node, liver and spleen were significantly reduced in iron
-loaded mice. Importantly, the "protective" effect of iron
delivery correlated with the presence, at the site of inoculation, of
lower levels of IL-4 and IL-10 transcripts while both IFN-gamma and
inducible nitric oxide synthase transcripts were at higher levels. The
presence of more type 1 cytokine transcripts was further supported by
the increased levels of IgG2a in their sera. These data strongly suggest
that susceptibility to L. major as assessed in the footpad model is
modifiable by interventions that alter the iron status of the host at
early time points of parasite delivery.
PMID: 11035745
TITLE: Essential role of platelet-activating factor in control of Leishmania
(Leishmania) amazonensis infection.
AUTHORS: M V Lonardoni, M Russo, S Jancar
AFFILIATION: Department of Clinical Analyses, State University of Maringá,
Maringá, Paraná, Brazil.
REFERENCE: Infect Immun 2000 Nov 68(11):6355-61
In the present study we investigated the role of platelet-activating
factor (PAF) and prostaglandins in experimental Leishmania (Leishmania)
amazonensis infection and the relationship between these mediators and
nitric oxide (NO) production. Mouse peritoneal macrophages elicited with
thioglicolate were infected with leishmania amastigotes, and the
infection index determined 48 h later. The course of infection was
monitored for 5 weeks in mice infected in the footpad with promastigotes
by measuring the footpad swelling and parasite load in regional lymph
nodes and spleen. The addition of PAF to C57BL/6 mouse macrophages
significantly inhibited parasite growth and induced NO production.
Treatment of macrophages with a selective PAF antagonist, WEB2086,
increased the infection, indicating that endogenously produced PAF
regulates macrophage ability to control leishmania infection. This
effect of PAF was abolished by addition of the inhibitor of NO synthesis
, L-NAME, to the cultures. The addition of prostaglandin E(2)
significantly increased the infection and NO production. Treatment with
cyclo-oxygenase inhibitor, indomethacin, reduced the infection and PAF-
induced release of NO. Thus, the increased NO production induced by PAF
seems to be mediated by prostaglandins. The more-selective inhibitors of
cyclo-oxygenase 2, nimesulide and NS-398, had no significant effect.
Thus, antileishmanial activity correlates better with the presence of
PAF or absence of prostaglandins than with NO production. In vivo
treatment with PAF antagonists significantly increased leishmania
lesions, as well as the parasite load, in regional lymph nodes and
spleens. These findings indicate that PAF is essential for the control
of leishmania infection.
PMID: 11069076
TITLE: Endogenous IL-4 is necessary for effective drug therapy against visceral
leishmaniasis.
AUTHORS: J Alexander, K C Carter, N Al-Fasi, A Satoskar, F Brombacher
AFFILIATION: Department of Immunology, University of Strathclyde, Glasgow, GB.
j.alexander at strath.ac.uk
REFERENCE: Eur J Immunol 2000 Oct 30(10):2935-43
It is well established that a fully competent immune response is
required for the successful drug treatment of visceral leishmaniasis.
However, recent studies have cast some doubt as to which elements of the
immune response synergize with chemotherapeutic treatment. The role of
the Th2 response and IL-4 in particular during visceral leishmaniasis
awaits clarification. We, therefore, examined the effectiveness of
sodium stibogluconate treatment on Leishmania donovani infection in BALB
/c wild-type and IL-4-/- mice. Parasite burdens in L. donovani-infected
IL-4+/- and IL-4-/-, as we have previously shown for B6/129 mice, were
similar, despite an apparent type 1 antibody response in infected IL-4
-/- mice, demonstrated by increased levels of parasite-specific IgG2a
and decreased IgG1. Unexpectedly IL-4-/- mice responded poorly to sodium
stibogluconate treatment with increased parasite burdens in all tissues
examined. Furthermore, drug therapy of IL-4-/- but not IL-4+/+ mice
resulted in significant reductions in splenocyte IFN-gamma mRNA
transcripts and in serum IFN-gamma levels. These results demonstrate
that IL-4 has an important role in effective anti-leishmanial
chemotherapy which seems to be related to modulation of IFN-gamma
production.
PMID: 11009089
TITLE: Peroxovanadium-mediated protection against murine leishmaniasis: role of
the modulation of nitric oxide.
AUTHORS: C Matte, J F Marquis, J Blanchette, P Gros, R Faure, B I Posner, M
Olivier
AFFILIATION: Centre de Recherche en Infectiologie and Département de Biologie
Médicale, Centre Hospitalier Universitaire de Québec, Faculté de Médecine,
Université Laval, Ste-Foy, Canada.
REFERENCE: Eur J Immunol 2000 Sep 30(9):2555-64
The phosphotyrosine phosphatase inhibitor bpV(phen) has the ability to
markedly decrease the progression of leishmaniasis in vivo. Here, we
have identified the mechanisms that are responsible for this protective
effect. We report that two potent peroxovanadium (pV) compounds, bpV(
phen) and bpV(pic), control progression of leishmaniasis in a similar
manner by modulating NO-dependent microbicidal action. We observed that
their injection can rapidly and transiently induce the expression of
inducible NO synthase (iNOS) in livers of mice and enhance circulating
nitrate levels. Treatment of mice with bpV(phen) or bpV(pic) completely
controlled progression of leishmaniasis in an NO-dependent manner, since
inhibition of iNOS with aminoguanidine completely reversed this pV-
mediated protection. This NO-dependent pV-mediated protection was
further demonstrated by the incapacity of bpV(phen)-treated Nramp-/-,
iNOS-/- mutant mice to control Leishmania major infection. Using an air
pouch model, we showed that bpV(phen) can strongly modulate secretion of
L. major-induced pro-inflammatory molecules and neutrophil recruitment
. In addition, we observed that bpV(phen) per se can strongly induce the
expression of Th1 type cytokines over Th2 in spleens of animals.
Overall, this study has allowed us to establish the in vivo functional
and immunological events involved in pV-mediated protective mechanism
against leishmaniasis and that NO plays a pivotal role in this process.
PMID: 10719664
TITLE: The role of nitric oxide in innate immunity.
AUTHORS: C Bogdan, M Röllinghoff, A Diefenbach
AFFILIATION: Institute of Clinical Microbiology, Immunology and Hygiene,
University of Erlangen, Germany. christian.bogdan at mikrobio.med.uni-erlangen.de
REFERENCE: Immunol Rev 2000 Feb 173():17-26
Type 2 nitric oxide synthase (iNOS or NOS2) was originally described as
an enzyme that is expressed in activated macrophages, generates nitric
oxide (NO) from the amino acid L-arginine, and thereby contributes to
the control of replication or killing of intracellular microbial
pathogens. Since interferon (IFN)-gamma is the key cytokine for the
induction of NOS2 in macrophages and the prototypic product of type 1 T-
helper cells, high-level expression of NOS2 has been regarded to be
mostly restricted to the adaptive phase of the immune response. In this
review, we summarize data that demonstrate a prominent role of NOS2/NO
also during innate immunity. During the early phase of infection with
the intracellular pathogen Leishmania major, focally expressed NOS2/NO
not only exerts antimicrobial activities but also controls the function
of natural killer cells and the expression of cytokines such as IFN-
gamma or transforming growth factor-beta. Some of these effects result
from the function of NOS2/NO as an indispensable co-factor for the
activation of Tyk2 kinase and, thus, for interleukin-12 and IFN-alpha/
beta signaling in natural killer cells.
PMID: 10761741
TITLE: Adenosine, AMP, and protein phosphatase activity in sandfly saliva.
AUTHORS: O Katz, J N Waitumbi, R Zer, A Warburg
AFFILIATION: Department of Parasitology, The Kuvin Center for the Study of
Infectious and Tropical Diseases, The Hebrew University-Hadassah Medical
School, Ein Kerem, Jerusalem, Israel.
REFERENCE: Am J Trop Med Hyg 2000 Jan 62(1):145-50
As they probe the skin for blood, sand flies inject saliva that prevents
hemostasis. Sand fly saliva also promotes leishmaniasis by suppressing
immunologic functions of macrophages. Saliva of Phlebotomus papatasi,
the vector of Old World cutaneous leishmaniasis, contains adenosine and
AMP. We show that Ph. papatasi saliva as well as pure adenosine down-
regulate the expression of the inducible nitric oxide (NO) synthase gene
in activated macrophages. In addition Ph. papatasi, but not Lutzomyia
longipalpis, saliva inhibits the production of NO. Taken together, these
data suggest that salivary adenosine is responsible for the down-
regulation of NO synthesis. Saliva of both genera Phlebotomus and
Lutzomyia contains significant levels of endogenous protein phosphatase-
1/2A-like activity that is heat labile, inhibitable by okadaic acid and
calyculine a, and does not require divalent cations.
PMID: 10647995
TITLE: Human monocytic U937 cells transfected with human hepatic inducible
nitric oxide synthase exhibit leishmanicidal activity.
AUTHORS: S Bertholet, J Mauël
AFFILIATION: Institute of Biochemistry, University of Lausanne, Switzerland.
Sylvie.BertholetGirardin at ib.unil.ch
REFERENCE: J Leukoc Biol 2000 Jan 67(1):34-9
In mice, the high inducible synthesis of nitric oxide (NO) resulting
from inducible NO synthase (iNOS, NOS2) expression by macrophages (Mphi
) is considered an essential component of the protective immune response
against infection by intracellular pathogens. Conversely, in humans,
the question of a role for NO as an antimicrobial defense mechanism has
been the subject of much debate. Recently, however, iNOS expression by
human Mphi and formation of NO or its derivatives have been reported
both in vivo and in vitro, strongly suggesting that human Mphi are
indeed capable of inducible NO synthesis. However, the conditions
allowing NO production by human Mphi in culture remain poorly defined,
rendering more difficult the study of the effector functions of NO in
these cells. To alleviate this problem, cells of the U937 monocytoid
line were engineered to express iNOS by transfection with human hepatic
iNOS (DFGiNOS), leading to production of NO on supplementation with the
cofactor tetrahydrobiopterin. We report that U937 cells, when
differentiated with 1,25-dihydroxyvitamin D3 and retinoic acid, acquire
a phenotype allowing infection by Leishmania parasites and maintain
viable intracellular microorganisms up to 72 h post-infection.
Leishmania survival in DFGiNOS cells is strongly decreased when the
cells are treated with tetrahydrobiopterin. Intracellular killing is
evident by 24 h and increases up to 72 h post-infection, and is
inhibited by L-N5-(1-iminoethyl)ornithine, an inhibitor of NO synthesis
. In contrast, superoxide anion does not appear to play a role in the
killing of Leishmania by DGFiNOS U937 cells. The relevance of this model
to the study of the mechanisms of intracellular killing by human
macrophages is discussed.
PMID: 10603400
TITLE: Roles of endogenous gamma interferon and macrophage microbicidal
mechanisms in host response to chemotherapy in experimental visceral
leishmaniasis.
AUTHORS: H W Murray, S Delph-Etienne
AFFILIATION: Department of Medicine, Weill Medical College of Cornell
University, New York, New York 10021, USA. hwmurray at mail.med.cornell.edu
REFERENCE: Infect Immun 2000 Jan 68(1):288-93
In experimental visceral leishmaniasis, in which the tissue macrophage
is the target, in vivo responsiveness to conventional chemotherapy (
pentavalent antimony [Sb]) requires a T-cell-dependent mechanism. To
determine if this mechanism involves gamma interferon (IFN-gamma)-
induced activation and/or specific IFN-gamma-regulated macrophage
leishmanicidal mechanisms (generation of reactive nitrogen or oxygen
intermediates, we treated gene-deficient mice infected with Leishmania
donovani. In IFN-gamma gene knockout (GKO) mice, Sb inhibited but did
not kill intracellular L. donovani (2% killing versus 76% in controls).
Sb was active (>94% killing), however, in both inducible nitric oxide
synthase (iNOS) knockout (KO) and respiratory burst (phagocyte oxidase)-
deficient chronic granulomatous disease (X-CGD) mice. Sb's efficacy was
also maintained in doubly deficient animals (X-CGD mice treated with an
iNOS inhibitor). In contrast to Sb, amphotericin B (AmB) induced high-
level killing in GKO mice; AmB was also fully active in iNOS KO and X-
CGD animals. Although resolution of L. donovani infection requires iNOS
, residual visceral infection remained largely suppressed in iNOS KO
mice treated with Sb or AmB. These results indicate that endogenous IFN-
gamma regulates the leishmanicidal response to Sb and achieves this
effect via a pathway unrelated to the macrophage's primary microbicidal
mechanisms. The role of IFN-gamma is selective, since it is not a
cofactor in the response to AmB. Treatment with either Sb or AmB permits
an iNOS-independent mechanism to emerge and control residual
intracellular L. donovani infection.
PMID: 10438370
TITLE: Synergistic effect of interferon-gamma and mannosylated
liposome-incorporated doxorubicin in the therapy of experimental visceral
leishmaniasis.
AUTHORS: L Kole, L Das, P K Das
AFFILIATION: Department of Molecular Cell Biology, Indian Institute of Chemical
Biology, Calcutta, India.
REFERENCE: J Infect Dis 1999 Sep 180(3):811-20
Active targeting of doxorubicin to macrophages was studied by
incorporating it in mannose-coated liposomes by use of visceral
leishmaniasis in BALB/c mice as the model macrophage disease.
Mannosylated liposomal doxorubicin was more effective than liposomal
doxorubicin or free doxorubicin. Because leishmaniasis is accompanied by
immunosuppression, immunostimulation by interferon (IFN)-gamma was
evaluated to act synergistically with mannosylated liposomal doxorubicin
therapy. Combination chemotherapy with a suboptimal dose of IFN-gamma
resulted in possibly complete elimination of spleen parasite burden.
Analysis of mRNA levels of infected spleen cells suggested that targeted
drug treatment together with IFN-gamma, in addition to greatly reducing
parasite numbers, resulted in reduced levels of interleukin (IL)-4 but
increased levels of IL-12 and inducible nitric oxide synthase. Such
combination chemotherapy may provide a promising alternative for the
cure of leishmaniasis, with a plausible conversion of antiparasitic T
cell response from a Th2 to Th1 pattern indicative of long-term
resistance.
PMID: 10487453
TITLE: A double-blind randomized clinical trial of a topical herbal extract
(Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous
leishmaniasis in Iran.
AUTHORS: F Zerehsaz, R Salmanpour, F Handjani, S Ardehali, M R Panjehshahin, S Z
Tabei, H R Tabatabaee
AFFILIATION: Shiraz Clinic and Department of Dermatology, Shiraz University of
Medical Sciences, Iran.
REFERENCE: Int J Dermatol 1999 Aug 38(8):610-2
PMID: 10458764
TITLE: Effects of nitric oxide on the induction and differentiation of Th1
cells.
AUTHORS: W Niedbala, X Q Wei, D Piedrafita, D Xu, F Y Liew
AFFILIATION: Department of Immunology, University of Glasgow, Glasgow, GB.
REFERENCE: Eur J Immunol 1999 Aug 29(8):2498-505
We have previously shown that mice lacking inducible NO synthase are
markedly more susceptible to Leishmania major infection but developed a
significantly enhanced Th1 cell response compared with wild-type mice.
Furthermore, at high concentrations, NO inhibited IL-12 synthesis by
activated macrophages, thereby indirectly suppressing the expansion of
Th1 cells. We report here that at low concentrations, NO selectively
enhanced the induction of Th1 cells and had no effect on Th2 cells. NO
exerted this effect in synergy with IL-12 during Th1 cell
differentiation and had no effect on fully committed Th1 cells. NO
appears to affect CD4(+) T cells directly and not at the antigen-
presenting cells. These results therefore provide an additional pathway
by which NO modulates the immune response and contributes to the
homeostasis of the immune system.
PMID: 10438949
TITLE: BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway
that controls susceptibility to infection by Leishmania major.
AUTHORS: A L Dent, T M Doherty, W E Paul, A Sher, L M Staudt
AFFILIATION: Metabolism Branch, National Cancer Institute, Laboratory of
Parasitic Diseases, National Institutes of Health, Bethesda, MD, USA.
REFERENCE: J Immunol 1999 Aug 163(4):2098-103
The BCL-6 gene negatively regulates Th2 responses as shown by the
finding that BCL-6-deficient (BCL-6-/-) mice develop a lethal Th2-type
inflammatory disease. The response of inbred mouse strains to infection
with Leishmania major is under genetic control; BALB/c mice are
susceptible and develop a progressive parasite burden, whereas most
other common laboratory strains of mice are resistant to infection. We
found that BCL-6-/- mice on a resistant genetic background (C57BL/6 x
129 intercrossed mice) were highly susceptible to L. major infection;
they resembled BALB/c mice in terms of lesion size, parasite load, and
the production of Th2 cytokines. BCL-6-/-IL-4-/- double-mutant mice were
also susceptible to L. major infection and produced 10-fold higher
levels of the Th2 cytokine IL-13 than IL-4-/- littermate controls. By
contrast, BCL-6-/-STAT6-/- double-mutant mice were resistant to L. major
infection despite also producing elevated levels of IL-13. These
results show that STAT6 is required for susceptibility to L. major
infection and suggest that IL-13 signaling through STAT6 may contribute
to a nonhealing, exacerbated L. major infection.
PMID: 10320373
TITLE: Requirement for type 2 NO synthase for IL-12 signaling in innate
immunity.
AUTHORS: A Diefenbach, H Schindler, M Röllinghoff, W M Yokoyama, C Bogdan
AFFILIATION: Institut für Klinische Mikrobiologie, Immunologie und Hygiene,
Universität Erlangen, Wasserturmstrasse 3, D-91054 Erlangen, Germany.
REFERENCE: Science 1999 May 284(5416):951-5
Interleukin-12 (IL-12) and type 2 NO synthase (NOS2) are crucial for
defense against bacterial and parasitic pathogens, but their
relationship in innate immunity is unknown. In the absence of NOS2
activity, IL-12 was unable to prevent spreading of Leishmania parasites
, did not stimulate natural killer (NK) cells for cytotoxicity or
interferon-gamma (IFN-gamma) release, and failed to activate Tyk2 kinase
and to tyrosine phosphorylate Stat4 (the central signal transducer of
IL-12) in NK cells. Activation of Tyk2 in NK cells by IFN-alpha/beta
also required NOS2. Thus, NOS2-derived NO is a prerequisite for cytokine
signaling and function in innate immunity.
PMID: 9989990
TITLE: Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus
oxygen intermediates in the killing of intracellular visceral Leishmania
donovani.
AUTHORS: H W Murray, C F Nathan
AFFILIATION: Department of Medicine, Division of Hematology-Oncology, Cornell
University Medical College, New York 10021, USA. hwmurray at mail.med.cornell.edu
REFERENCE: J Exp Med 1999 Feb 189(4):741-6
To determine the relative contributions of respiratory burst-derived
reactive oxygen intermediates (ROI) versus reactive nitrogen
intermediates (RNI) to macrophage-mediated intracellular host defense,
mice genetically deficient in these mechanisms were challenged with
Leishmania donovani, a protozoan that selectively parasitizes visceral
tissue macrophages. During the early stage of liver infection at wk 2,
both respiratory burst-deficient gp91(phox)-/- (X-linked chronic
granulomatous disease [X-CGD]) mice and inducible nitric oxide synthase
(iNOS) knockout (KO) mice displayed comparably increased susceptibility
. Thereafter, infection was unrestrained in mice lacking iNOS but was
fully controlled in X-CGD mice. Mononuclear cell influx into infected
liver foci in X-CGD and iNOS KO mice was also overtly impaired at wk 2.
However, granuloma assembly in parasitized tissue eventually developed
in both hosts but with divergent effects: mature granulomas were
functionally active (leishmanicidal) in X-CGD mice but inert in iNOS-
deficient animals. These results suggest that (a) ROI and RNI probably
act together in the early stage of intracellular infection to regulate
both tissue recruitment of mononuclear inflammatory cells and the
initial extent of microbial replication, (b) RNI alone are necessary and
sufficient for eventual control of visceral infection, and (c) although
mature granulomas have traditionally been associated with control of
such infections, these structures fail to limit intracellular parasite
replication in the absence of iNOS.
PMID: 10592110
TITLE: Inducible nitric oxide synthase and nitric oxide production in Leishmania
infantum-infected human macrophages stimulated with interferon-gamma and
bacterial lipopolysaccharide.
AUTHORS: M A Panaro, A Acquafredda, S Lisi, D D Lofrumento, T Trotta, R
Satalino, M Saccia, V Mitolo, O Brandonisio
AFFILIATION: Istituto di Anatomia Umana Normale, University of Bari,
Policlinico, I-70124, Bari, Italy.
REFERENCE: Int J Clin Lab Res 1999 29(3):122-7
Nitric oxide produced by an inducible nitric oxide synthase constitutes
one of the main microbicidal mechanisms of murine macrophages and its
importance is now being recognized for human macrophages. In this study
we evaluated inducible nitric oxide synthase expression, nitric oxide
release, and parasitocidal ability of Leishmania infantum-infected
monocyte-derived human macrophages. The inducible nitric oxide synthase
was detected by immunofluorescence and western blotting and nitric oxide
production was measured by the Griess reaction for nitrites. Parasite
killing was microscopically evaluated by fluorescent dyes. Experiments
were performed on macrophages with or without previous stimulation with
recombinant human interferon-gamma and bacterial lipopolysaccharide.
Inducible nitric oxide synthase expression and nitric oxide release were
higher in Leishmania-infected stimulated macrophages than in uninfected
cells or infected cells without previous stimulation. Nitric oxide
production and parasitocidal activity against Leishmania infantum were
reduced in macrophages treated with the nitric oxide synthase inhibitor
L-N(G) monomethylarginine. These results suggest a microbicidal role for
nitric oxide in human leishmaniasis, with the possible practical
application of immunological or pharmacological regulation of nitric
oxide synthesis in the treatment of this infection.
PMID: 9820534
TITLE: Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1,
but up-regulates a Th2, response in mice infected with Leishmania major.
AUTHORS: M L Mbow, J A Bleyenberg, L R Hall, R G Titus
AFFILIATION: Department of Pathology, Colorado State University College of
Veterinary Medicine and Biomedical Sciences, Fort Collins 80523-1671, USA.
REFERENCE: J Immunol 1998 Nov 161(10):5571-7
A vertebrate host becomes infected with Leishmania major when the sand
fly vector injects parasites into skin along with saliva. Previous
studies showed that salivary gland lysate of the New World sand fly
Lutzomyia longipalpis markedly enhanced L. major infection in CBA mice.
However, L. major is an Old World parasite transmitted in nature by the
Old World sand fly Phlebotomus papatasi. Here we examine the ability of
P. papatasi salivary gland lysate to enhance infection (lesion size and
parasite burden) by L. major. In addition, we examine the effects of
salivary gland lysate on the immune response to L. major by monitoring
the levels of cytokine mRNA from the lymph nodes draining cutaneous
lesions. We found that P. papatasi salivary gland lysate dramatically
exacerbated lesion development in disease-resistant CBA mice. This
exacerbation of disease correlated with inhibition of the production of
Thl cytokines and associated factors (IFN-gamma, IL-12, and inducible
nitric oxide synthase), but with enhancement of the Th2 cytokine IL-4,
whereas no changes in the levels of IL-10 and TGF-beta were noted.
Importantly, salivary gland lysate directly up-regulated expression of
IL-4 mRNA in mice in the absence of infection with L. major.
PMID: 9924547
TITLE: Lack of a nitric-oxide response during the course of Leishmania infantum
infection in the golden hamster (Mesocricetus auratus), with or without
treatment with liposomal amphotericin B.
AUTHORS: C Bories, C Coffin, D Mathieu, P N Bories, E Scherman, D Rivollet, M
Deniau
AFFILIATION: Service de Radiologie, Centre Hospitalier Universitaire Henri
Mondor, Créteil, France. Christian.Bories at cep.u-psud.fr
REFERENCE: Ann Trop Med Parasitol 1998 Sep 92(6):685-92
Liver and spleen volumes and serum concentrations of nitrate (the end-
product of NO in vivo), albumin, gamma-globulin, protein, creatine and
urea were measured during the course of progressive infections with
Leishmania infantum MON-1 (MHOM/PR/93/CRE29) in 10 Syrian golden
hamsters. Each hamster was infected by intraperitoneal injection with 4
x 10(7) promastigotes. Five of the infected animals were treated, with 6
mg liposomal amphotericin B (L-AmB)/kg given by intracardiac injection
, on day 107 post-infection (p.i.). Compared with those in the
uninfected hamsters used as controls, the liver volumes in the infected
animals became significantly enlarged by day 40 p.i. (38% larger than
the controls; P < 0.001) whereas significant enlargement of the
spleen was first detected on day 72. Each infected animal had detectable
serum levels of antileishmanial antibodies on day 72. There were
significant elevations in gamma-globulin concentration as early as day
40 (P < 0.05) but significant falls in albumin concentrations were
only detected from day 107 (P < 0.001). Nitrate, creatinine and urea
concentrations remained unchanged during the course of infection, even
after L-AmB treatment. Serum nitrate levels were not enhanced by L.
infantum infection nor by the L-AmB treatment which induced a 98.2%
decrease in parasite burden. The lack of NO production in visceral
leishmaniasis, with or without L-AmB treatment, points to the
unresponsiveness of inducible nitric oxide synthase in this rodent model.
PMID: 9725203
TITLE: Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with
cathepsin B inhibitor in experimental leishmaniasis.
AUTHORS: Y Maekawa, K Himeno, H Ishikawa, H Hisaeda, T Sakai, T Dainichi, T
Asao, R A Good, N Katunuma
AFFILIATION: Department of Parasitology and Immunology, University of Tokushima
School of Medicine, Japan.
REFERENCE: J Immunol 1998 Sep 161(5):2120-7
When activated, CD4+ T helper cells differentiate functionally into one
of two subsets, Th1 or Th2. Before the Th differentiation, Ags must be
processed into peptide epitopes and presented to CD4+ T cells in
association with MHC class II molecules. However, the proteases
responsible for this Ag processing have not been well defined. When BALB
/c mice susceptible to infection with Leishmania major were treated with
a specific inhibitor (CA074) of cathepsin B, a lysosomal cysteine
protease that digests exogenous antigenic proteins, those mice acquired
resistance against infection with L. major and showed the shift of
immune responses from Th2 to Th1; that is, they produced specific IgG2a
Ab and generated IFN-gamma in contrast to untreated and infected mice
that produced IgG1 and IgE and generated IL-4. CA074 interfered with the
digestion of L. major Ags with lysosomal enzymes in vivo as well as in
vitro. However, this inhibitor did not show any direct influence on the
growth of L. major and the functions of T cells stimulated with anti-CD3
Ab. These findings indicate that cathepsin B inhibitor could switch CD4
+ T cell differentiation from Th2 to Th1, suggesting that the alteration
in Ag processing modulates the polarity of Th differentiation.
PMID: 9605154
TITLE: Control of Leishmania major infection in mice lacking TNF receptors.
AUTHORS: M Nashleanas, S Kanaly, P Scott
AFFILIATION: University of Pennsylvania School of Veterinary Medicine,
Philadelphia 19104, USA.
REFERENCE: J Immunol 1998 Jun 160(11):5506-13
TNF participates in the induction of nitric oxide (NO) production and
macrophage activation, leading to the elimination of intracellular
pathogens. We previously found that TNF receptor p55-deficient mice (
TNFRp55-/-) control replication of Leishmania major in vivo but fail to
resolve their lesions. Here we report that mice lacking the p75 receptor
(TNFRp75-/-) or both receptors (TNFRp55p75-/-), also control parasite
replication, albeit mice lacking the p55 receptor (either TNFRp55-/- or
TNFRp55p75-/-) are delayed in their elimination of L. major compared
with controls. All TNF receptor-deficient mice developed a Thl-type
immune response and up-regulated inducible NO synthase (iNOS) mRNA gene
expression in lesions during infection. Thus, neither TNF receptor
appears to be absolutely required for NO production or elimination of L
. major in vivo. In vitro, however, while macrophages from naive TNFRp75
-/- mice could be activated to produce NO and kill L. major, we observed
a defect in NO production and parasite killing by resident peritoneal
macrophages from naive TNFRp55-/- or TNFRp55p75-/- mice. However, when
macrophages were elicited with leishmanial Ag from 4-wk-infected TNFRp55
-/- or TNFRp55p75-/- mice, they produced NO and were leishmanicidal.
These data suggest that the TNFRp75 plays no essential role in L. major
infection in mice and that the p55 receptor may be required for optimal
macrophage activation. However, the results also show that a mechanism
exists by which macrophages can be primed in vivo during L. major
infection to produce NO and kill L. major in the absence of signaling
through either of the TNF receptors.
PMID: 9529078
TITLE: Phlebotomus papatasi saliva inhibits protein phosphatase activity and
nitric oxide production by murine macrophages.
AUTHORS: J Waitumbi, A Warburg
AFFILIATION: Department of Parasitology, The Kuvin Center for the Study of
Infectious and Tropical Diseases, Hebrew University-Hadassah Medical School,
Jerusalem, Israel.
REFERENCE: Infect Immun 1998 Apr 66(4):1534-7
Leishmania parasites, transmitted by phlebotomine sand flies, are
obligate intracellular parasites of macrophages. The sand fly
Phlebotomus papatasi is the vector of Leishmania major, a causative
agent of cutaneous leishmaniasis in the Old World, and its saliva
exacerbates parasite proliferation and lesion growth in experimental
cutaneous leishmaniasis. Here we show that P. papatasi saliva contains a
potent inhibitor of protein phosphatase 1 and protein phosphatase 2A of
murine macrophages. We further demonstrate that P. papatasi saliva down
regulates expression of the inducible nitric oxide synthase gene and
reduces nitric oxide production in murine macrophages. Partial
biochemical characterization of the protein phosphatase and nitric oxide
inhibitor indicated that it is a small, ethanol-soluble molecule
resistant to boiling, proteolysis, and DNase and RNase treatments. We
suggest that the P. papatasi salivary protein phosphatase inhibitor
interferes with the ability of activated macrophages to transmit signals
to the nucleus, thereby preventing up regulation of the induced nitric
oxide synthase gene and inhibiting the production of nitric oxide. Since
nitric oxide is toxic to intracellular parasites, the salivary protein
phosphatase inhibitor may be the mechanism by which P. papatasi saliva
exacerbates cutaneous leishmaniasis.
PMID: 9570545
TITLE: Protective effect on Leishmania major infection of migration inhibitory
factor, TNF-alpha, and IFN-gamma administered orally via attenuated Salmonella
typhimurium.
AUTHORS: D Xu, S J McSorley, L Tetley, S Chatfield, G Dougan, W L Chan, A
Satoskar, J R David, F Y Liew
AFFILIATION: Department of Immunology, University of Glasgow, United Kingdom.
REFERENCE: J Immunol 1998 Feb 160(3):1285-9
The genes encoding murine macrophage migration inhibitory factor (MIF),
IL-2, IFN-gamma or TNF-alpha were cloned individually into an expression
plasmid under the control of the inducible promoter nirB and
transfected into the aroA- aroD- deletion mutant strain of Salmonella
typhimurium (BRD509). These S. typhimurium derivatives (henceforward
called constructs and termed GIDMIF, GIDIL2, GIDIFN and GIDTNF)
expressed their respective cytokines in vitro under anaerobic conditions
and stably colonized BALB/c mice up to 14 days after oral
administration. The highly susceptible BALB/c mice that had received the
constructs orally and that had been subsequently infected via the
footpad with Leishmania major, developed significantly reduced disease
compared with control mice administered the untransfected Salmonella
strain (BRD509). Importantly, a combination of GIDMIF, GIDIFN, and
GIDTNF administered orally after L. major infection was able to
significantly limit lesion development and reduced parasite loads by up
to three orders of magnitude. Spleen and lymph node cells of mice
administered this combination expressed markedly higher levels of
inducible nitric oxide synthase (iNOS) compared with those from mice
receiving an equivalent dose of the control strain of Salmonella (BRD509
). These data therefore demonstrate the feasibility of therapeutic
treatment in an infectious disease model using cytokines delivered by
attenuated Salmonella. The protective effect observed correlates with
the induction of inducible nitric oxide synthase in vivo.
PMID: 9261952
TITLE: Haemolytic activities of plant saponins and adjuvants. Effect of
Periandra mediterranea saponin on the humoral response to the FML antigen of
Leishmania donovani.
AUTHORS: W R Santos, R R Bernardo, L M Peçanha, M Palatnik, J P Parente, C B
Palatnik de Sousa
AFFILIATION: Instituto de Microbiologia, Universidade Federal do Rio de Janeiro
(UFRJ), CCS, Cidade Universitária, Brazil.
REFERENCE: Vaccine 1997 Jun 15(9):1024-9
An 87.7% (P < 0.01) and 84% (P < 0.001) of protection against
visceral leishmaniasis was achieved in CB hamsters and Balb/c mice,
respectively, with saponin combined to the fucose-mannose ligand of
Leishmania donovani (FML). However, an undesirable haemolytic effect was
described for several saponins. Aiming to improve the formulation with
FML/saponin, we comparatively analysed the haemolytic potential of
recently characterized plant saponins and currently used adjuvants. The
haemolytic activity of steroidic saponins from Agave sisalana; Smilax
officinalis as well as commercial saponin (Riedel De Haën's), was
higher than that of triterpenoid ones (Bredemeyera floribunda; Periandra
mediterranea) and the Freund's complete adjuvant. The concentration
resulting in 50% haemolysis was 500 micrograms ml-1 for aluminum
hydroxide. The low haemolytic effect of P. mediterranea saponin was
abolished by removal of its glycidic moiety and its sapogenin fraction
as well as the Freund's Incomplete Adjuvant were non-haemolytic within
this range. Furthermore, the adjuvant effect of three doses of P.
mediterranea saponin injected with the FML antigen of L. donovani, was
assayed in mice, either by the intraperitoneal (i.p.) or the
subcutaneous (s.c.) route. The anti-FML IgG antibody levels increased
and detectable levels were observed up to 3 months in the s.c. group.
The response was expanded in both groups after an injection with a
fourth vaccine dose. The IgG response showed increased levels of IgG2a
only in the i.p. group, while IgG2b and IgG1 but not IgG3 antibodies
were higher than controls in both groups. In conclusion, the results
suggest that the recently described triterpenoid fractions of P.
mediterranea can be safely used as adjuvant with low or non-haemolytic
effect.
PMID: 8713607
TITLE: The FML (Fucose Mannose Ligand) of Leishmania donovani. a new tool in
diagnosis, prognosis, transfusional control and vaccination against human
kala-azar.
AUTHORS: C B Palatnik de Sousa, E M Gomes, E P de Souza, W R dos Santos, S R de
Macedo, L V de Medeiros, K Luz
AFFILIATION: Instituto de Microbiologia, Universidade Federal do Rio de
Janeiro.
REFERENCE: Rev Soc Bras Med Trop 1996 Mar-Apr 29(2):153-63
The Fucose-Mannose Ligand (FML) of Leishmania donovani is a complex
glycoproteic fraction. Its potential use as a tool for diagnosis of
human visceral leishmaniasis was tested with human sera from Natal, Rio
Grande do Norte, Brazil. The FML-ELISA test, showed 100% sensitivity and
96% specificity, identifying patients with overt kala-azar (p < 0.
001, when compared to normal sera), and subjects with subclinical
infection. More than 20% apparently healthy subjects with positive
reaction to FML developed overt kala-azar during the following 10 months
. In the screening of human blood donnors, a prevalence of 5% of
sororeactive subjects was detected, attaining 17% in a single day. The
GP36 glycoprotein of FHL is specifically reconized by human kala-azar
sera. The immunoprotective effect of FML on experimental L. donovani
infection was tested in swiss albino mice. The protection scheemes
included three weekly doses of FML, supplemented or not with saponin by
the subcutaneous or intraperitoneal routes and challenge with 2 x 10(7)
amastigotes of Leishmania donovani. An enhancement of 80.0% in antibody
response (p < 0.001) and reduction of 85.5% parasite liver burden (p
< 0.001) was detected in animals immunized with FML saponin,
unrespectively of the immunization route.
PMID: 3324215
TITLE: The discovery of urea stibamine.
AUTHORS: P D Marsden
REFERENCE: Rev Soc Bras Med Trop 1986 Apr-Jun 19(2):115
REQUEST: [ leishmania ]
(112 articles match this request. 69 articles matching other requests removed)
PMID: 15722039
TITLE: LdARL-1 His-tagged recombinant protein: purification by immobilized metal
affinity expanded bed adsorption.
AUTHORS: Annelise Sahin, Emmanuel Tetaud, Gilles Merlin, Xavier Santarelli
AFFILIATION: CNRS UMR 5162 Génomique Fonctionnelle des Trypanosomatides,
Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux
cedex, France.
REFERENCE: J Chromatogr B Analyt Technol Biomed Life Sci 2005 Apr 818(1):19-22
Previously we have cloned three ADP-ribosylation factor-like (ARL) genes
from the parasitic protozoan Leishmania donovani: LdARL-3A and 3B,
LdARL-1. LdARL-3A was previously purified as an active native form,
which was able to bind GTP in vitro. In this paper, we have performed
the production and the purification of Histidine-tagged (His-tagged)
LdARL-1 recombinant protein by immobilized metal affinity chromatography
(IMAC) using expanded bed adsorption (EBA) technology. This protein was
purified with more than 95% purity and could be successfully used for
GTP-binding assay.
PMID: 15720561
TITLE: Leishmania salvage and remodelling of host sphingolipids in amastigote
survival and acidocalcisome biogenesis.
AUTHORS: Kai Zhang, Fong-Fu Hsu, David A Scott, Roberto Docampo, John Turk,
Stephen M Beverley
AFFILIATION: Department of Molecular Microbiology, Box 8230, Washington
University School of Medicine, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
REFERENCE: Mol Microbiol 2005 Mar 55(5):1566-78
Summary Sphingolipids (SLs) play essential roles in most eukaryotes, but
in the trypanosomatid protozoan Leishmania major their functions differ
significantly. Previously we showed that null mutants defective in de
novo sphingoid base synthesis (spt2(-)) lacked SLs but grew well and
retained lipid rafts while replicating as promastigotes in vitro.
However, they experienced catastrophic defects in membrane trafficking
on entry into stationary phase, and failed to differentiate to the
infective metacyclic form. Here we showed this mutant retained the
ability to enter macrophages silently and inhibit activation, although
as expected most parasites were destroyed. However, in mouse infections
, after a delay rapidly progressive lesions appeared, and purified
amastigotes were fully virulent to macrophages and mice. Mass
spectrometry of spt2(-) amastigote lipids revealed the presence of high
levels of parasite-specific inositol phosphorylceramides (IPCs) not
synthesized by the mammalian hosts. Inhibitor studies showed that
salvage occurs at the level of complex SLs, suggesting that parasites
carry out 'headgroup' remodelling. Additionally, we describe a new
defect of the spt2(-) promastigotes involving 'empty' acidocalcisomes (
ACs), which may point to the origin of this organelle from the lysosome-
related organelle/multivesicular body biogenesis pathway. However, ACs
in spt2(-) amastigotes appeared quantitatively and morphologically
normal. Thus salvage of SLs and other molecules by intracellular
amastigotes play key roles in AC biogenesis and parasite survival in the
host.
PMID: 15721837
TITLE: Leishmania donovani engages in regulatory interference by targeting
macrophage protein tyrosine phosphatase SHP-1.
AUTHORS: Devki Nandan, Neil E Reiner
AFFILIATION: Division of Infectious Diseases, Department of Medicine, Faculties
of Medicine and Science, Vancouver Coastal Health Research Institute (VCHRI),
The University of British Columbia, Vancouver, British Columbia, Canada.
REFERENCE: Clin Immunol 2005 Mar 114(3):266-77
Protozoan parasites of the genus leishmania are obligate intracellular
parasites of monocytes and macrophages. These pathogens have evolved to
invade the mammalian immune system and typically survive for long
periods of time. Leishmania have developed a variety of remarkable
strategies to prevent their elimination by both innate and acquired
immune effector mechanisms. One particular strategy of interest involves
manipulation of host cell regulatory pathways so as to prevent
macrophage activation required for efficient microbicidal activity.
These interference mechanisms are the main focus of this review. Several
lines of evidence have been developed to show that the Src homology-2
domain containing tyrosine phosphatase-1 (SHP-1) becomes activated in
leishmania-infected cells and that this contributes to disease
pathogenesis. Recent studies aimed at understanding the mechanism
responsible for the change in activation state of SHP-1 led to the
identification of leishmania EF-1alpha as an SHP-1 binding protein and
SHP-1 activator. This was a surprising finding given that this
ubiquitous and highly conserved protein plays an essential role in
protein translation in both prokaryotic and eukaryotic cells. The role
of leishmania EF-1alpha as an SHP-1 activator and its contribution to
pathogenesis are reviewed with particular attention to the properties
that distinguish it from host EF-1alpha.
PMID: 15721836
TITLE: Modulation of phagolysosome biogenesis by the lipophosphoglycan of
Leishmania.
AUTHORS: Robert Lodge, Albert Descoteaux
AFFILIATION: INRS-Institut Armand-Frappier, Université du Québec, Laval QC,
Canada H7V 1B7.
REFERENCE: Clin Immunol 2005 Mar 114(3):256-65
Promastigotes of the protozoan parasite Leishmania are inoculated into
the mammalian host by an infected sandfly and are phagocytosed by
macrophages. There, they differentiate into amastigotes, which replicate
in phagolysosomes. A family of glycoconjugates, the phosphoglycans (PGs
), plays an important role in the ability of promastigotes to survive
the potentially microbicidal consequences of phagocytosis.
Lipophosphoglycan (LPG), an abundant promastigote surface glycolipid,
has received considerable attention over the past several years. Of
interest for this review, lipophosphoglycan confers upon Leishmania
donovani promastigotes the ability to inhibit phagolysosome biogenesis.
This inhibition correlates with an accumulation of periphagosomal F-
actin, which may potentially form a physical barrier that prevents L.
donovani promastigote-harboring phagosomes from interacting with late
endosomes and lysosomes. Thus, similar to several other pathogens,
Leishmania promastigotes hijack the host cell's cytoskeleton early
during the infection process. Here, we review this phenomenon and
discuss the potential underlying mechanisms.
PMID: 15713445
TITLE: Strand asymmetry patterns in trypanosomatid parasites.
AUTHORS: Daniel Nilsson, Björn Andersson
AFFILIATION: Center for Genomics and Bioinformatics, Karolinska Institutet,
Berzeliusv. 35, SE-171 77 Stockholm, Sweden.
REFERENCE: Exp Parasitol 2005 Mar 109(3):143-9
The genome organization of kinetoplastid parasites is unusual, with
chromosomes containing several long regions of polycistronically
transcribed genes. The regions where the direction of transcription
switches have been hypothesized to contain origins of replication and
possibly also centromers and promoters. We report that overall strand
asymmetry patterns can be observed in Trypanosoma cruzi and Trypanosoma
brucei with optima on strand-switch regions. The base skews of T. cruzi
and T. brucei divergent strand-switches show patterns analogous to those
for bacterial origins of replication, but they differ from those of
Leishmania major. Bias in codon usage and the trypanosomatid
unidirectional gene clusters predict most of this skew, but fail to
properly explain the same trend in intergenic regions, as does the
current knowledge of regulatory sequences.
PMID: 15708793
TITLE: Water soluble cationic trans-platinum complexes which induce programmed
cell death in the protozoan parasite Leishmania infantum.
AUTHORS: Paul A Nguewa, Miguel A Fuertes, Salvador Iborra, Yousef Najajreh, Dani
Gibson, Enrique MartÃnez, Carlos Alonso, José M Pérez
AFFILIATION: Departamento de ParasitologÃa, Facultad de Farmacia, Universidad
de la Laguna, Tenerife, Spain.
REFERENCE: J Inorg Biochem 2005 Mar 99(3):727-36
We have evaluated the cytotoxic properties against the protozoan
Leishmania infantum of four water soluble cationic trans-Pt(II)Cl(2)
compounds containing as inert groups NH(3) and piperazine (1), 4-
picoline and piperazine (2), n-butylamine and piperazine (3), and NH(3)
and 4-piperidino-piperidine (4). The leishmanicidal activity of
compounds 3 and 4 against promastigotes of the parasite Leishmania
infantum was 2.5- and 1.6-times higher than that of the cytotoxic drug
cis-diamminedichloroplatinum(II), respectively. Interestingly, compounds
3 and 4 produce in Leishmania infantum promastigotes a higher amount of
programmed cell death than cisplatin, which is associated with cell
cycle arrest in G2/M. In contrast to cis-diamminedichloroplatinum(II),
binding of compounds 3 and 4 to calf thymus DNA induces conformational
changes more similar to those of trans-diamminedichloroplatinum(II) that
may be attributed to denaturation of the double helix. Similarly to cis
-diamminedichloroplatinum(II) and trans-diamminedichloroplatinum(II),
the interaction of compounds 3 and 4 with ubiquitin results in an
increase of the alpha-helix content of the protein as observed by
circular dichroism spectroscopy. However, fluorescence studies indicate
that compounds 3 and 4 produce a decrease in the fluorescence of the
tyrosine 59 residue of ubiquitin higher than both cis-
diamminedichloroplatinum(II) and trans-diamminedichloroplatinum(II).
Altogether, our results suggest that the biochemical mechanism of
cytotoxic activity of compounds 3 and 4 against Leishmania infantum must
be different from that of cis-diamminedichloroplatinum(II). To the best
of our knowledge, compounds 3 and 4 are the first reported trans-
platinum complexes that show antiparasitic activity.
PMID: 15720564
TITLE: LmxMPK9, a mitogen-activated protein kinase homologue affects flagellar
length in Leishmania mexicana.
AUTHORS: Florian Bengs, Anne Scholz, Daniela Kuhn, Martin Wiese
AFFILIATION: Bernhard Nocht Institute for Tropical Medicine, Parasitology
Section, Bernhard-Nocht-Strasse 74, D-20359 Hamburg, Germany.
REFERENCE: Mol Microbiol 2005 Mar 55(5):1606-15
Summary Components of mitogen-activated signal transduction pathways
have been shown to be involved in flagellum biogenesis and maintenance.
A mitogen-activated protein kinase homologue, designated LmxMPK9 from
Leishmania mexicana, has been recently identified in a homology screen
and its mRNA found to be present in all life stages. Three different
splice-addition sites were used for mRNA maturation in trans-splicing in
the different life stages. However, here we show that LmxMPK9 protein
is exclusively found in the promastigote stage. Recombinant expression
of LmxMPK9 in Escherichia coli and kinase assays revealed a temperature
optimum at 27 degrees C, the optimal growth temperature for L. mexicana
promastigotes, and a preference for manganese to promote substrate
phosphorylation of myelin basic protein. A deletion mutant for the
single-copy gene revealed significantly elongated flagella, whereas
overexpression led to a subpopulation with rather short to no flagella
suggesting a role for LmxMPK9 in flagellar morphogenesis.
PMID: 15710544
TITLE: Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and
amastigotes.
AUTHORS: Wagner Weber Arrais-Silva, Marcelle Carolina Collhone, Diana Copi
Ayres, Paula Cristina de Souza Souto, Selma Giorgio
AFFILIATION: Department of Parasitology, Biology Institute, Universidade
Estadual de Campinas, Caixa Postal 6109, Cep 13083-970, Campinas, São Paulo,
Brazil.
REFERENCE: Parasitol Int 2005 Mar 54(1):1-7
In the present study, we evaluated the effects of hyperbaric oxygen (HBO
) exposure in both Leishmania amazonensis life stages (promastigotes and
amastigotes) and on macrophage cultures infected with the parasite. HBO
treatment protocols, which can be tolerated by humans and animals,
induced irreversible metabolic damage and affected parasite morphology,
growth and ability to transform. The observation that the antioxidant N-
acetylcysteine (NAC) prevents some of these deleterious effects
indicated an involvement of oxidative stress during parasite HBO
exposure. In addition, HBO exposed L. amazonensis-infected macrophage
cultures showed reduction of the percentage of infected cells and of the
number of intracellular parasites per cell. Thus, the demonstration
that HBO, a therapy used in the management of different diseases, is
toxic for both L. amazonensis life stages and can alter macrophage
susceptibility to the infection encourages further studies of this
therapy in animal models of Leishmania infection.
PMID: 15657927
TITLE: Selective targeting of indel-inferred differences in spatial structures
of highly homologous proteins.
AUTHORS: Artem Cherkasov, Devki Nandan, Neil E Reiner
AFFILIATION: Department of Medicine (Division of Infectious Diseases),
University of British Columbia, Vancouver, British Columbia, Canada.
REFERENCE: Proteins 2005 Mar 58(4):950-4
Recent findings have shown that the protein elongation factor-1alpha (EF
-1alpha) from the eukaryotic pathogen Leishmania donovani possesses
virulence properties. This was unexpected, since it has greater than 80
% sequence identity with its human homologue. Given that EF-1alpha is
essential for cell survival, in principle, it can be considered an
attractive drug target. However, the challenge is to be able to
selectively target the protein so as not to affect function of the human
homologue. While a limited number of discrete differences were
scattered throughout the sequence, most of the difference between these
2 homologues could be attributed to a 12-amino acid insert present in
human EF-1alpha and absent from the leishmania sequence. In the present
study, we modeled the spatial differences in structures of human and L.
donovani EF-1alpha's inferred by this insertion-deletion (or "indel
"). The protein models were used to develop antibodies directed
specifically toward the deletion region of the pathogen protein. The
strategy described allowed successful selective targeting of this
putative leishmania virulence factor while avoiding recognition of the
highly similar human EF-1alpha homologue. These findings may establish a
new strategy for the development of antagonists directed against
certain pathogenic targets having close human homologues. Proteins 2005
(c) 2005 Wiley-Liss, Inc.
PMID: 15722076
TITLE: Leishmania braziliensis: a novel mechanism in the lipophosphoglycan
regulation during metacyclogenesis.
AUTHORS: Rodrigo P P Soares, Tatiana L Cardoso, Tamara Barron, Márcio S S
Araújo, Paulo F P Pimenta, Salvatore J Turco
AFFILIATION: Department of Biochemistry, University of Kentucky Medical Center,
Lexington, KY 40536, USA.
REFERENCE: Int J Parasitol 2005 Mar 35(3):245-53
During metacyclogenesis of Leishmania in its sand fly vector, the
parasite differentiates from a noninfective, procyclic form to an
infective, metacyclic form, a process characterised by morphological
changes of the parasite and also biochemical transformations in its
major surface lipophosphoglycan (LPG). This lipid-anchored
polysaccharide is polymorphic among species with variations in sugars
that branch off the conserved Gal(beta1,4)Man(alpha1)-PO(4) backbone of
repeat units and the oligosaccharide cap. Lipophosphoglycan has been
implicated as an adhesion molecule that mediates the interaction with
the midgut epithelium of the sand fly in the subgenus Leishmania. This
paper describes the LPG structure for the first time in a species from
the subgenus Viannia, Leishmania (Viannia) braziliensis. The LPG from
the procyclic form of L. braziliensis was found to lack side chain sugar
substitutions. In contrast to other species from the subgenus
Leishmania, metacyclic forms of L. braziliensis makes less LPG and add 1
-2 (beta1-3) glucose residues that branch off the disaccharide-phosphate
repeat units of LPG. Thus, this represents a novel mechanism in the
regulation of LPG structure during metacyclogenesis.
PMID: 15691375
TITLE: Role of Leishmania (Leishmania) chagasi amastigote cysteine protease in
intracellular parasite survival: studies by gene disruption and antisense mRNA
inhibition.
AUTHORS: Vasanthakrishna Mundodi, Ashwini S Kucknoor, Lashitew Gedamu
AFFILIATION: Department of Biological Sciences, University of Calgary, Calgary
AB T2N1N4, Canada. lgedamu at ucalgary.ca.
REFERENCE: BMC Mol Biol 2005 Feb 6(1):3
BACKGROUND: The parasitic protozoa belonging to Leishmania (L.) donovani
complex possess abundant, developmentally regulated cathepsin L-like
cysteine proteases. Previously, we have reported the isolation of
cysteine protease gene, Ldccys2 from Leishmania (L.) chagasi. Here, we
have further characterized this cysteine protease gene and demonstrated
its role during infection and survival of Leishmania (L.) chagasi within
the U937 macrophage cells. RESULTS: The amastigote specific Ldccys2
genes of L. (L.) chagasi and L. (L.) donovani have identical gene
organization, as determined by southern blots. In vivo expression
analyses by Northern blots showed that Ldccys2 is amastigote specific.
Western blot using anti-Ldccys2 antibody confirmed the amastigote
specific protein expression. Recombinant expression of Ldccys2, a 30 kDA
protein, was functionally active in a gelatin assay. Results from
Ldccys2 heterozygous knockout mutants showed its role during macrophage
infection and in intra-macrophage survival of the parasites. Since
attempts to generate null mutants failed, we used antisense RNA
inhibition to regulate Ldcccys2 gene expression. Not surprisingly, the
results from antisense studies further confirmed the results from
heterozygous knockout mutants, reiterating the importance of amastigote
specific cysteine proteases in Leishmania infection and pathogenesis.
CONCLUSIONS: The study shows that Ldccys2 is a developmentally regulated
gene and that Ldccys2 is expressed only in infectious amastigote stages
of the parasite. The collective results from both the heterozygous
knockout mutants and antisense mRNA inhibition studies shows that
Ldccys2 helps in infection and survival of L. (L.) chagasi amastigotes
within the macrophage cells. Finally, antisense RNA technique can be
used as an alternate approach to gene knockout, for silencing gene
expression in L. (L.) chagasi, especially in cases such as this, where a
null mutant cannot be achieved by homologous recombination.
PMID: 15579464
TITLE: Hemoglobin receptor in leishmania is a hexokinase located in the
flagellar pocket.
AUTHORS: Ganga Krishnamurthy, Rajagopal Vikram, Sudha B Singh, Nitin Patel,
Shruti Agarwal, Gauranga Mukhopadhyay, Sandip K Basu, Amitabha Mukhopadhyay
AFFILIATION: National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi
110067, India and Center for Molecular Medicine, Jawaharlal Nehru University,
New Delhi 110067, India.
REFERENCE: J Biol Chem 2005 Feb 280(7):5884-91
Hb endocytosis in Leishmania is mediated through a 46-kDa protein
located in the flagellar pocket. To understand the nature of the Hb
receptor (HbR), we have purified the 46-kDa protein to homogeneity from
Leishmania promastigote membrane. Purified HbR specifically binds Hb.
The gene for HbR was cloned, and sequence analysis of the full-length
HbR gene indicates the presence of hexokinase (HK) signature sequences,
ATP-binding domain, and PTS-II motif. Four lines of evidence indicate
that HbR in Leishmania is a hexokinase: 1) the recombinant HbR binds Hb
, and the Hb-binding domain resides in the N terminus of the protein; 2
) recombinant proteins and cell lysate prepared from HbR-overexpressing
Leishmania promastigotes show enhanced HK activity in comparison with
untransfected cells; 3) immunolocalization studies using antibodies
against the N-terminal fragment (Ld-HbR-DeltaC) of Ld-HbR indicate that
this protein is located in the flagellar pocket of Leishmania; and 4)
binding and uptake of (125)I-Hb by Leishmania is significantly inhibited
by anti-Ld-HbR-DeltaC antibody and Ld-HbR-DeltaC, respectively. Taken
together, these results indicate that HK present in the flagellar pocket
of Leishmania is involved in Hb endocytosis.
PMID: 15619607
TITLE: Correction of Translational Defects in Patient-derived Mutant
Mitochondria by Complex-mediated Import of a Cytoplasmic tRNA.
AUTHORS: Bidesh Mahata, Suvendra Nath Bhattacharyya, Saikat Mukherjee, Samit
Adhya
AFFILIATION: Genetic Engineering Laboratory, Indian Institute of Chemical
Biology, 4 Raja S. C. Mullick Road, Calcutta 7000032, India.
REFERENCE: J Biol Chem 2005 Feb 280(7):5141-4
A variety of clinical disorders result from mutations in mitochondrial
tRNA genes, leading to translational defects. We show here that a
protein complex from the kinetoplastid protozoon Leishmania induces
specific, ATP-dependent import of human cytoplasmic tRNA(1)(Lys) into
human mitochondria in vitro. The imported tRNA undergoes efficient
aminoacylation within the organelle and supports organellar protein
synthesis. Moreover, translation in mitochondria from patients with
myclonic epilepsy with ragged red fibers (MERRF) and Kearns-Sayre
syndrome (KSS), containing mutant tRNA(Lys) genes, is stimulated to near
-wild-type levels and the formation of aberrant polypeptides suppressed
by complex-mediated import. These results suggest a novel way to
introduce RNAs for the modulation of mitochondrial gene expression.
PMID: 15561707
TITLE: Molecular characterization, expression, and in vivo analysis of LmexCht1:
the chitinase of the human pathogen, Leishmania mexicana.
AUTHORS: Manju B Joshi, Matthew E Rogers, Alison M Shakarian, Mat Yamage, Saeed
A Al-Harthi, Paul A Bates, Dennis M Dwyer
AFFILIATION: Cell Biology Section, Laboratory of Parasitic Diseases, NIAID,
National Institutes of Health, Bethesda, Maryland 20892-0425, USA.
REFERENCE: J Biol Chem 2005 Feb 280(5):3847-61
Chitinases have been implicated to be of importance in the life cycle
development and transmission of a variety of parasitic organisms. Using
a molecular approach, we identified and characterized the structure of a
single copy LmexCht1-chitinase gene from the primitive trypanosomatid
pathogen of humans, Leishmania mexicana. The LmexCht1 encodes an
approximately 50 kDa protein, with well conserved substrate binding and
catalytic domains characteristic of members of the chitinase-18 protein
family. Further, we showed that LmexCht1 mRNA is constitutively
expressed by both the insect vector (i.e. promastigote) and mammalian (i
.e. amastigote) life cycle developmental forms of this protozoan
parasite. Interestingly, however, amastigotes were found to secrete/
release approximately >2-4-fold higher levels of chitinase activity
during their growth in vitro than promastigotes. Moreover, a homologous
episomal expression system was devised and used to express an epitope-
tagged LmexCht1 chimeric construct in these parasites. Expression of the
LmexCht1 chimera was verified in these transfectants by reverse
transcription-PCR, Western blots, and indirect immunofluorescence
analyses. Further, results of coupled immunoprecipitation/enzyme
activity experiments demonstrated that the LmexCht1 chimeric protein was
secreted/released by these transfected L. mexicana parasites and that
it possessed functional chitinase enzyme activity. Such transfectants
were also evaluated for their infectivity both in human macrophages in
vitro and in two different strains of mice. Results of those experiments
demonstrated that the LmexCht1 transfectants survived significantly
better in human macrophages and also produced significantly larger
lesions in mice than control parasites. Taken together, our results
indicate that the LmexCht1-chimera afforded a definitive survival
advantage to the parasite within these mammalian hosts. Thus, the
LmexCht1 could potentially represent a new virulence determinant in the
mammalian phase of this important human pathogen.
PMID: 15715010
TITLE: Detection of Leishmania infantum in canine peripheral blood.
AUTHORS: V Foglia Manzillo, D Piantedosi, L Cortese
AFFILIATION: Dipartimento di Scienze Cliniche Veterinarie, Sezione Clinica
Medica, Università degli Studi di Napoli Federico II, via F. Delpino 1,80137
Naples, Italy.
REFERENCE: Vet Rec 2005 Jan 156(5):151-2
PMID: 15539112
TITLE: Rocking the curve.
AUTHORS: Marc Choisy, Mallorie Hide, Anne-Laure Bañuls, Jean-François Guégan
REFERENCE: Trends Microbiol 2004 Dec 12(12):534-6
PMID: 15711773
TITLE: Regulation of k-cl cotransport: from function to genes.
AUTHORS: N C Adragna, M Di Fulvio, P K Lauf
AFFILIATION: Departments of Pharmacology and Toxicology, Wright State
University, School of Medicine, Dayton, OH, 45435-0002, USA,
norma.adragna at wright.edu.
REFERENCE: J Membr Biol 2004 Oct 201(3):109-37
This review intends to summarize the vast literature on K-Cl cotransport
(COT) regulation from a functional and genetic viewpoint. Special
attention has been given to the signaling pathways involved in the
transporter's regulation found in several tissues and cell types, and
more specifically, in vascular smooth muscle cells (VSMCs). The number
of publications on K-Cl COT has been steadily increasing since its
discovery at the beginning of the 1980s, with red blood cells (RBCs)
from different species (human, sheep, dog, rabbit, guinea pig, turkey,
duck, frog, rat, mouse, fish, and lamprey) being the most studied model
. Other tissues/cell types under study are brain, kidney, epithelia,
muscle/smooth muscle, tumor cells, heart, liver, insect cells,
endothelial cells, bone, platelets, thymocytes and Leishmania donovani.
One of the salient properties of K-Cl-COT is its activation by cell
swelling and its participation in the recovery of cell volume, a process
known as regulatory volume decrease (RVD). Activation by thiol
modification with N-ethylmaleimide (NEM) has spawned investigations on
the redox dependence of K-Cl COT, and is used as a positive control for
the operation of the system in many tissues and cells. The most accepted
model of K-Cl COT regulation proposes protein kinases and phosphatases
linked in a chain of phosphorylation/dephosphorylation events. More
recent studies include regulatory pathways involving the phosphatidyl
inositol/protein kinase C (PKC)-mediated pathway for regulation by
lithium (Li) in low-K sheep red blood cells (LK SRBCs), and the nitric
oxide (NO)/cGMP/protein kinase G (PKG) pathway as well as the platelet-
derived growth factor (PDGF)-mediated mechanism in VSMCs. Studies on VSM
transfected cells containing the PKG catalytic domain demonstrated the
participation of this enzyme in K-Cl COT regulation. Commonly used
vasodilators activate K-Cl COT in a dose-dependent manner through the NO
/cGMP/PKG pathway. Interaction between the cotransporter and the
cytoskeleton appears to depend on the cellular origin and experimental
conditions. Pathophysiologically, K-Cl COT is altered in sickle cell
anemia and neuropathies, and it has also been proposed to play a role in
blood pressure control. Four closely related human genes code for KCCs
(KCC1-4). Although considerable information is accumulating on tissue
distribution, function and pathologies associated with the different
isoforms, little is known about the genetic regulation of the KCC genes
in terms of transcriptional and post-transcriptional regulation. A few
reports indicate that the NO/cGMP/PKG signaling pathway regulates KCC1
and KCC3 mRNA expression in VSMCs at the post-transcriptional level.
However, the detailed mechanisms of post-transcriptional regulation of
KCC genes and of regulation of KCC2 and KCC4 mRNA expression are unknown
. The K-Cl COT field is expected to expand further over the next decades
, as new isoforms and/or regulatory pathways are discovered and its
implication in health and disease is revealed.
PMID: 15601228
TITLE: The choice of animal model and reduction.
AUTHORS: Michael F W Festing
AFFILIATION: FRAME, Russell & Burch House, 96-98 North Sherwood Street,
Nottingham NG1 4EE, UK.
REFERENCE: Altern Lab Anim 2004 Sep 32 Suppl 2():59-64
Careful choice of the animal model is essential, if research is to be
conducted efficiently, by using the minimum number of animals in order
to provide the maximum amount of information. Inbred strains of rodents
provide an excellent way of controlling and investigating genetic
variation in characters of interest and in response to experimental
treatments. Outbred stocks, in which genetic and non-genetic factors are
inextricably mixed, are much less suitable, because random and
uncontrolled genetic variation tends to obscure any treatment responses
. In some cases, the use of inbred strains has led to major advances in
scientific understanding. The specific example given here is in the
understanding of host-parasite relationships but, more generally, inbred
strains have been of critical importance in research which has resulted
in the award of at least 17 Nobel prizes. And yet, despite the
extensive literature on the properties and scientific value of inbred
strains, many scientists continue to use outbred stocks in the mistaken
belief that the use of such animals will, in some mysterious way, make
their research more applicable to humans. There is really no evidence
that this is so, and there is much evidence that the use of inbred
strains has been highly successful in many disciplines.
PMID: 15183913
TITLE: Piperazine-linked bisbenzamidines: a novel class of antileishmanial
agents.
AUTHORS: Annie Mayence, Jean Jacques Vanden Eynde, Louis LeCour, Larry A Walker,
Babu L Tekwani, Tien L Huang
AFFILIATION: Division of Basic Pharmaceutical Sciences, College of Pharmacy,
Xavier University of Louisiana, 1 Drexel Drive, New Orleans, LA 70125, USA.
REFERENCE: Eur J Med Chem 2004 Jun 39(6):547-53
A series of 13 1,4-diarylpiperazines has been prepared, evaluated for
antileishmanial activity and their binding affinity to DNA was measured
. Among these compounds, 1,4-bis[4-(1H-benzimidazol-2-yl)phenyl]
piperazine (14) emerged as the most active compound with an IC(50) value
of 0.41 microM which is about sevenfold more potent than pentamidine.
********************************************************************************************************************
The following references are revised files and are brought to you in accordance
to license agreement with the NLM.
********************************************************************************************************************
PMID: 15474490
TITLE: Toxoplasma gondii exposes phosphatidylserine inducing a TGF-beta1
autocrine effect orchestrating macrophage evasion.
AUTHORS: Sergio H Seabra, Wanderley de Souza, Renato A Damatta
AFFILIATION: Laboratório de Biologia Celular e Tecidual, Centro de Biociências
e Biotecnologia, Universidade Estadual do Norte Fluminense, 28013-600 Campos dos
Goytacazes, RJ, Brazil.
REFERENCE: Biochem Biophys Res Commun 2004 Nov 324(2):744-52
Toxoplasmosis is a worldwide disease caused by Toxoplasma gondii.
Activated macrophages control T. gondii growth by nitric oxide (NO)
production. However, T. gondii active invasion inhibits NO production,
allowing parasite persistence. Here we show that the mechanism used by T
. gondii to inhibit NO production persisting in activated macrophages
depends on phosphatidylserine (PS) exposure. Masking PS with annexin-V
on parasites or activated macrophages abolished NO production inhibition
and parasite persistence. NO production inhibition depended on a
transforming growth factor-beta1 (TGF-beta1) autocrine effect confirmed
by the expression of Smad 2 and 3 in infected macrophages. TGF-beta1 led
to inducible nitric oxide synthase (iNOS) degradation, actin filament (
F-actin) depolymerization, and lack of nuclear factor-kappaB (NF-kappaB
) in the nucleus. All these features were reverted by TGF-beta1
neutralizing antibody treatment. Thus, T. gondii mimics the evasion
mechanism used by Leishmania amazonensis and also the anti-inflammatory
response evoked by apoptotic cells.
You receive this email because you requested RefScout®'s literature
update.
If you would like to change or add requests, please go to your user
profile.
If you can't read our newsletter, please resend newsletter back to us to
info at refscout.com, including information
about your operating system and mail client software you use, and we will do
our
best to solve the problem.
If you would like to be removed from RefScout®'s literature service, please
press the
remove button.
DISCLAIMER
----- End forwarded message -----
More information about the Leish-l
mailing list